WO2008048626A2 - Methods and devices for catheter advancement and delivery of substances therethrough - Google Patents

Methods and devices for catheter advancement and delivery of substances therethrough Download PDF

Info

Publication number
WO2008048626A2
WO2008048626A2 PCT/US2007/022122 US2007022122W WO2008048626A2 WO 2008048626 A2 WO2008048626 A2 WO 2008048626A2 US 2007022122 W US2007022122 W US 2007022122W WO 2008048626 A2 WO2008048626 A2 WO 2008048626A2
Authority
WO
WIPO (PCT)
Prior art keywords
catheter
guide element
anchor
catheters
delivery catheter
Prior art date
Application number
PCT/US2007/022122
Other languages
French (fr)
Other versions
WO2008048626A3 (en
Inventor
Niel F. Starksen
Karl S. Im
Mariel Fabro
Stephen Meier
Eugene Serina
Original Assignee
Guided Delivery Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guided Delivery Systems, Inc. filed Critical Guided Delivery Systems, Inc.
Priority to EP07852809A priority Critical patent/EP2081627A4/en
Priority to JP2009533354A priority patent/JP2010506658A/en
Priority to AU2007313197A priority patent/AU2007313197B2/en
Priority to EP18167829.3A priority patent/EP3420921B1/en
Priority to CA2666862A priority patent/CA2666862C/en
Publication of WO2008048626A2 publication Critical patent/WO2008048626A2/en
Publication of WO2008048626A3 publication Critical patent/WO2008048626A3/en
Priority to IL198206A priority patent/IL198206A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B17/0644Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/068Surgical staplers, e.g. containing multiple staples or clamps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3468Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0485Devices or means, e.g. loops, for capturing the suture thread and threading it through an opening of a suturing instrument or needle eyelet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00778Operations on blood vessels
    • A61B2017/00783Valvuloplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B2017/0496Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06004Means for attaching suture to needle
    • A61B2017/06019Means for attaching suture to needle by means of a suture-receiving lateral eyelet machined in the needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466Delivery devices therefor

Definitions

  • the methods and devices described herein relate generally to the field of advancement of catheters over a guide element and delivery of substances through those catheters (e.g., implants, such as anchors or leads, or drugs). More specifically, the methods described here are in the field of successive advancement of a plurality of catheters over a guide element where the guide element is attached to a body tissue that is accessible minimally invasively, or where the guide clement if left behind as an implant. The methods and devices described here may have particular utility in the area of mitral valve repair.
  • Rapid-exchange catheters generally include a guidewire lumen that extends for only a portion of the length of the catheter shaft.
  • a rapid-exchange catheter may be relatively easily threaded over a guidewire, delivered to a target site, and withdrawn from the target site. Because rapid-exchange catheters do not need to be threaded over the entire length of a guidewire, rapid-exchange catheters may be relatively short in length. In some variations, a rapid-exchange catheter may be shorter in length than the guidewire over which the rapid- exchange catheter is advanced. The guidewire, in turn, may also be relatively short in length.
  • a rapid-exchange catheter After being withdrawn from a target site, a rapid-exchange catheter can be removed from the guidewire over which it was threaded, and exchanged with another rapid-exchange catheter, which, in turn, can be delivered to the target site over the guidewire.
  • Some methods of removing a rapid-exchange catheter from a guidewire include withdrawing the rapid-exchange catheter over the guidewire.
  • Other methods include using a rapid-exchange catheter with a perforated sheath, and splitting the sheath open at its perforations to remove the rapid-exchange catheter from the guidewire.
  • rapid-exchange procedures can allow for different types of catheters (e.g., catheters having balloons of different sizes or catheters carrying different therapeutic agents) to be efficiently delivered to a target site in one procedure.
  • catheters e.g., catheters having balloons of different sizes or catheters carrying different therapeutic agents
  • the use of rapid-exchange catheters in a procedure may result in a reduction in the number of operations required to complete the procedure.
  • Over-the-wire catheters generally include a guidewire lumen that extends along the entire length of the catheter shaft. Over-the-wire catheters may be used, for example, in peripheral procedures, such as balloon angioplasty procedures. An over-the-wire catheter may be relatively easily tracked over a guidewire and delivered to a target site. Once the over- the-wire catheter has been used to perform a procedure at the target site, it may be withdrawn over the guidewire and removed from the subject.
  • Some of the methods described here generally comprise successively advancing a plurality of catheters over a guide element, wherein the guide element is attached to a body tissue.
  • the body tissue may be accessible minimally invasively.
  • the guide element may not be detached from the body tissue after the catheters have been advanced over the guide element.
  • the methods may further comprise deploying at least one implant from at least one of the plurality of catheters.
  • the implant may be any suitable implant. For example, it may be an anchor, a lead or electrode, or any other implant capable of fixedly securing the tether to the body tissue.
  • the implant is an anchor, and the anchor is configured to self-expand and self-secure into a region of the body tissue.
  • the body tissue may be any body tissue that is accessible minimally invasively, and in some variations, the body tissue comprises heart tissue (e.g., mitral valve tissue).
  • the methods may be used to deploy a series of anchors (that are carried in one or more catheters) in the region of a heart valve annulus of a subject in order to reduce mitral valve regurgitation.
  • the catheter may be a guide catheter, a sheath, a drug delivery catheter, a therapeutic catheter, a termination catheter, a cutting catheter, a locking catheter, a diagnostic catheter, a tool catheter, or any other suitable catheter.
  • Some methods may include advancing one type of catheter over the guide element, and then advancing a different type of catheter over the guide element.
  • Other methods described here comprise advancing a first delivery catheter to a first region of a body tissue, deploying a first anchor from the first delivery catheter, wherein the first anchor is attached to a guide element, proximally withdrawing the first delivery catheter, advancing a second delivery catheter over the guide element, and deploying a second anchor from the second delivery catheter.
  • the second anchor may be slidably coupled to the guide element, so that the guide element will not be held rigidly in place at the site of the second anchor deployment.
  • the anchors may have eyelets through which the guide element may be slidably disposed.
  • the guide element may be slidably coupled to the anchor with the use of a lasso prior to insertion in the delivery catheter.
  • the first and second anchors can be deployed to the same region or different regions of the body tissue, and any number of anchors may be deployed as desirable.
  • the anchors self-expand and self-secure into different regions of the body tissue.
  • any number or type of catheters may be used, and in some variations, advancing the first delivery catheter to the first region of the body tissue comprises advancing the first delivery catheter through a tunnel catheter.
  • the tunnel catheter may have an opening positioned along its side wall, or otherwise positioned proximally of its distal tip, and in some variations, the first delivery catheter is advanced through the opening.
  • any of the catheters. described here may be pre-shaped or pre-formed in some fashion or in a particular geometry. For example, in some instances, it may be desirable for the catheter to include one or more curves to better conform to the target anatomy. In some of the variations described here, the distal portion of the tunnel catheter is pre-shaped to include at least one curve.
  • the catheters may also have any number of suitable lumens, such as lumens that are configured to allow passage of a guide element therethrough. In some variations, a catheter described here may have a lumen that is located in either a proximal section or a distal section of the catheter, but not in both sections.
  • the guide element may comprise or be made from any suitable material.
  • the guide element may be made from an artificial or natural suture material, or it may be made from a metal or shape memory alloy.
  • the guide element may be made from one or more absorbable materials, and/or one or more non-absorbable materials.
  • the guide element is made from polyester impregnated with polytetrafluoroethylene.
  • the guide element is a tether (e.g., a suture).
  • the guide element may be in the form of a wire.
  • the guide element may be braided or woven, and/or may include multiple different layers.
  • these methods may deploy any number of anchors, and in some variations, the anchors are deployed into heart tissue, e.g., heart tissue in the region of the mitral valve.
  • the guide element the delivery catheters were advanced over may be cinched, or pulled proximally.
  • the result may be a geometric change in at least one of the mitral valve annulus and the tissue surrounding the mitral valve annulus, a reduction in the circumference of the mitral valve annulus, enhancement of mitral valve leaflet apposition, and/or a reduction in mitral valve regurgitation.
  • Devices for stabilizing a catheter with respect to a body tissue comprise a catheter having an expandable member configured to engage against a first portion of tissue in order to stabilize the catheter with respect to a second portion of tissue.
  • the expandable member may be any member suitable for providing such stabilization.
  • the expandable member may be a low-pressure inflatable balloon made of a compliant material, or the expandable member may be made of a shape memory material, such as a nickel titanium alloy basket or wing.
  • a low-pressure balloon is used and only a portion of the balloon is configured to inflate.
  • the catheters comprise at least one lumen.
  • the catheters comprise a first and a second lumen where the first and second lumens are positioned adjacent to one another, where at least a portion of the first and second lumens are configured to allow the passage of the guide element therethrough, and where the second lumen is accessible from the first lumen.
  • the catheter may be any suitable catheter and may have any number of desirable functions (e.g., the catheter may be a cutting catheter, a termination catheter, a device delivery catheter, a drug delivery catheter, a therapeutic catheter, a diagnostic catheter, a tool catheter, etc.).
  • the catheter may be a therapeutic catheter that is configured for use in tissue altering therapy, such as ablation.
  • the catheter is a device delivery catheter used for electrical pacing or for delivery of at least one anchor.
  • the anchor is typically positioned in the first lumen.
  • FIG. 1 is a cross-sectional view of a heart.
  • FIG. 2 is a cross-sectional view of a portion of a heart.
  • FIG. 3A is a flowchart representation of a method for delivering at least two anchors into a region of a heart valve annulus.
  • FIGS. 3B-3E schematically depict variations of anchor deployment.
  • FIGS. 4A-4I provide a detailed depiction of a method for advancing at least two delivery catheters to the sub-annular groove ("SAG") of a heart valve to deliver at least two anchors into a region of a heart valve annulus.
  • SAG sub-annular groove
  • FIG. 4J is an enlarged view of region 4J of FIG. 41.
  • FIGS. 5A-5D illustrate a method for engaging a guide element with an anchor.
  • FIGS. 6A-6F depict different variations of lassos.
  • FIG. 7 A is a perspective view of a locking catheter.
  • FIG. 7B is a cross-sectional view of the locking catheter of FIG. 7 A, taken along line 7B-7B.
  • FIG. 8 A is a cross-sectional view of a portion of a tunnel catheter through which a delivery catheter is advanced
  • FIG. 8B is a side cross-sectional view of the tunnel catheter of FIG. 8 A
  • FIG. 8C is a side cross-sectional view of the tunnel catheter of FIG. 8A.
  • FIG. 9 is a cross-sectional view of a portion of a tunnel catheter through which a delivery catheter is advanced.
  • FIGS. 10A- 1OE are side views of different routing configurations of guide elements in locking catheters.
  • FIGS. 1 IA-11C are side views of different routing configurations of guide elements in cutting catheters.
  • FIG. 12A is a perspective view of a delivery catheter
  • FIG. 12B is a front view of the delivery catheter of FIG. 12 A
  • FIGS. 12C and 12D are side and bottom views, respectively, of a portion of the delivery catheter of FIG. 12 A.
  • FIGS. 13A-13C depict various expandable members that may be used to help stabilize a catheter in the SAG.
  • FIG. 14A is a perspective view of a tunnel catheter.
  • FIG. 14B is a cross-sectional view of the tunnel catheter of FIG. 14A, taken along line 14B-14B.
  • Described here are methods for successively advancing a plurality of catheters over a guide element, and method and devices for delivering anchors to a region of a body tissue. It should be understood from the outset that while methods of advancing a plurality of catheters to heart valve tissue are described in detail here, the methods may be used, and are contemplated for use, with any body tissue that may be accessed minimally invasively. Examples of body tissue that may be accessed minimally invasively include body tissue that may be accessed percutaneously (e.g., intravascularly), laparoscopically, endoscopically, robotically, and/or through one or more airways.
  • the methods may be applied to the coronary sinus, the tricuspid valve, the left and/or right ventricles, and/or one or more veins.
  • the methods may be used with the bladder, the urethra, the lungs, the stomach, the liver, the kidneys, the gallbladder, and/or in peripheral applications (e.g., in the legs).
  • the methods may be used in gastrointestinal applications or in transbrachial applications.
  • the methods may be used to deliver therapy, such as tissue modification, electrical pacing, or an implant.
  • the guide element may be used to facilitate delivery of one or more tools to a target site.
  • the guide element may be used to facilitate a robotic procedure, such as the robotic delivery of one or more tools to a target site.
  • the methods of advancing a plurality of catheters over a guide element comprise advancing multiple catheters over a guide element, where the guide element is attached to body tissue that is accessible minimally invasively.
  • the methods may comprise deploying at least one implant from one of the catheters.
  • the implant may be any suitable or desirable implant.
  • the implant may be a lead or electrode, an anchor, or any other implant.
  • the implant may also be of any suitable shape and size.
  • anchors When anchors are used, they may be configured to self-expand and self-secure into the tissue. Suitable anchors and guide elements will be described in more detail below.
  • any suitable catheter may be used and advanced over the guide element.
  • the catheter may be a guide catheter, a sheath, a drug delivery catheter, a therapeutic catheter, a termination catheter, a locking catheter, a cutting catheter, a diagnostic catheter, a tool catheter, or any other suitable catheter.
  • a guide catheter a sheath
  • a drug delivery catheter a therapeutic catheter
  • a termination catheter a termination catheter
  • a locking catheter a cutting catheter
  • a diagnostic catheter a tool catheter, or any other suitable catheter.
  • these methods generally comprise advancing a first delivery catheter to a first region of a body tissue, deploying a first anchor from the first delivery catheter, wherein the first anchor is attached to a guide element, proximally withdrawing the first delivery catheter, advancing a second delivery catheter over the guide element, and deploying a second anchor from the second delivery catheter.
  • these methods may deploy any number of anchors, and in some variations, the anchors are deployed into heart tissue, e.g., tissue in the region of the mitral valve.
  • the guide element the delivery catheters were advanced over may be cinched, or pulled proximally to reduce the circumference of the mitral valve annulus.
  • a mitral valve may be repaired using a relatively efficient and minimally invasive procedure.
  • the use of a single guide element to deliver multiple delivery catheters and/or to deploy multiple anchors may result in reduced procedure time and a reduced likelihood of error in anchor placement.
  • the use of a single anchored guide element may allow for the delivery of multiple delivery catheters and/or deployment of multiple anchors to a target site, without requiring visualization of the delivery and/or deployment.
  • the guide element may be fixedly attached or otherwise secured to a target site and used as a track for the delivery of multiple delivery catheters and/or deployment of multiple anchors to the target site, and also may be left at the target site when the procedure is finished, to serve as an implant itself.
  • FIG. 1 is a cross-sectional schematic representation of a heart (100).
  • heart (100) includes the superior vena cava (SVC), the right atrium (RA), the right ventricle (RV), the tricuspid valve leaflets (TVL), the aorta (A), the mitral valve leaflets (MVL), the left atrium (LA), and the left ventricle (LV).
  • SVC superior vena cava
  • RA right atrium
  • RV right ventricle
  • RV tricuspid valve leaflets
  • A the aorta
  • A the mitral valve leaflets
  • LA left atrium
  • LV left ventricle
  • LV left ventricle
  • the mitral valve has two leaflets (MVL), the anteromedial leaflet and the posterolateral leaflet.
  • mitral valve annulus Surrounding the opening of the mitral valve is a fibrous ring known as the mitral valve annulus.
  • a normally functioning mitral valve allows blood to flow into the left ventricle during ventricular diastole, and prevents blood from going from the ventricle to the left atrium during systole, in a retrograde fashion.
  • a mitral valve that allows blood to flow into the left atrium is said to have regurgitation, and in instances where the regurgitation is severe, mitral valve repair may be desirable.
  • FIG. 2 provides a schematic cross-sectional view of a portion 200 of the mitral valve (MV) anatomy.
  • portion (200) includes a mitral valve leaflet (MVL).
  • the annulus (AN), which surrounds the valve, is also shown.
  • the SAG is the track defined by the joinder of the horizontal underside of the mitral valve annulus (AN) with the ventricular wall (VW).
  • An equivalent subannular groove is positioned on the underside of the tricuspid valve, and the methods and devices described here may be used with respect to the tricuspid valve as well.
  • a catheter may be inserted into the femoral artery and passed through the right atrium (RA), through the interatrial septum in the area of the foramen ovale behind the aorta (A), and into the left ventricle. Upon further advancement, the distal portion of the catheter will naturally travel under the posterolateral valve leaflet into the SAG. The catheter may be further advanced along the SAG, either partially or completely around the circumference of the valve. It is often desirable to have the catheter seated at the intersection of the mitral valve leaflets (MVL) and the ventricular wall, adjacent to, and very near the annulus from the underside.
  • MCL mitral valve leaflets
  • a pre- shaped catheter e.g., a catheter having a pre-shaped distal end or portion
  • a pre-shaped catheter may aid in placement by conforming to the target anatomy. While the approach described above employs access through the femoral artery, access may be obtained through other suitable vessels as well (e.g., the jugular artery).
  • FIG. 3 A provides a flowchart depiction of a method (300) for deploying at least two anchors in the region of a heart valve annulus.
  • this illustrative method comprises advancing a guide catheter to the SAG (310), advancing a guidewire through a lumen of the guide catheter (320), advancing a tunnel catheter over the guidewire (330), and proximally withdrawing the guidewire from the tunnel catheter (340).
  • a first delivery catheter may be advanced through the lumen of the tunnel catheter (350) and a first anchor may be deployed into a first region of the heart valve annulus (360).
  • the first anchor is typically fixedly attached or otherwise secured to a guide element, such as a tether.
  • a guide element such as a tether.
  • the guide element may be made from any suitable or desirable biocompatible material.
  • the guide element may be braided or not braided, woven or not woven, reinforced or impregnated with additional materials, or may be made of a single material or a combination of materials.
  • the guide element may be made from a suture material (e.g., absorbable suture materials such as polyglycolic acid and polydioxanone, natural fibers such as silk, and artificial fibers such as polypropylene, polyester, polyester impregnated with polytetrafluoroethylene, nylon, etc.), may be made from a metal (absorbable or non-absorbable), may be made from a metal alloy (e.g., stainless steel), may be made from a shape memory material, such as a shape memory alloy (e.g., a nickel titanium alloy), may be made from combinations thereof, or may be made from any other biocompatible material.
  • a suture material e.g., absorbable suture materials such as polyglycolic acid and polydioxanone, natural fibers such as silk, and artificial fibers such as polypropylene, polyester, polyester impregnated with polytetrafluoroethylene, nylon, etc.
  • a metal e.g., stainless steel
  • the guide element when pulled proximally, the guide element will cinch or reduce the circumference of the mitral valve annulus.
  • the guide element may be in the form of a wire.
  • the guide element may include multiple layers, and/or may include one or more coatings.
  • the guide element may be in the form of a polymer-coated wire.
  • the guide element may be formed of a combination of one or more sutures and one or more wires.
  • the guide element may be formed of a suture that is braided with a wire.
  • the guide element may be formed of one or more electrode materials.
  • the guide element may be formed of one or more materials that provide for the telemetry of information (e.g., regarding the condition of the target site).
  • the guide element may include one or more therapeutic agents (e.g., drugs, such as time-release drugs).
  • the guide element may be partially or entirely coated with one or more therapeutic agents.
  • the guide element may be used to deliver one or more growth factors and/or genetic regenerative factors.
  • the guide element may be coated with a material (e.g., a polymer) that encapsulates one or more therapeutic agents, or in which one or more therapeutic agents are embedded.
  • the therapeutic agents may be used, for example, to treat the target site to which the guide element is fixedly attached or otherwise secured.
  • the guide element may include one or more lumens through which a therapeutic agent can be delivered.
  • the first delivery catheter is withdrawn proximally and the tunnel catheter is positioned at a different location about the SAG (370).
  • a second delivery catheter is then advanced over the guide element through the lumen of the tunnel catheter (380).
  • the guide element may enter the second delivery catheter through an opening at its distal end, and exit the second delivery catheter through an opening in its side wall that is proximal to its distal end.
  • the guide element may enter the second delivery catheter through an opening at its distal end, and exit the second delivery catheter through an opening at its proximal end.
  • a second anchor is deployed into a second region of the heart valve annulus (390).
  • FIGS. 3B and 3C depict the mitral valve (MV) of FIG. 2 schematically from an inferior perspective looking up.
  • anchors (392) are shown deployed in the mitral valve in an anterior-posterior fashion
  • FIG. 3C anchors (394) are shown deployed in a transverse fashion.
  • FIG. 3D pairs, or sets of two anchors (396) are shown deployed.
  • any number of anchors e.g., two, three, four, five, six, seven, etc. may make up a set, and that the sets need not be symmetrically or evenly spaced about the annulus as shown in FIG. 3D.
  • the anchors (or sets of anchors) may be deployed symmetrically or evenly spaced about the annulus as shown in FIG. 3E with reference to anchors (398), but they need not be.
  • FIG. 3 A shows multiple anchors being delivered via multiple delivery catheters
  • other methods of delivering the anchors may be used. For example, it some instances, it may be desirable to deliver multiple anchors from a single delivery catheter as described in more detail in U.S. Pat. Appl. Serial No. 11/201,949, which is hereby incorporated by reference in its entirety. Similarly, it may be desirable to combine multiple anchor delivery and deployment via a single delivery catheter with single anchor delivery and deployment via a single delivery catheter. Ordinary artisans will choose the number and type of catheters most appropriate for their procedure and circumstances.
  • FIGS. 4A-4I provide a more detailed depiction of the method shown in flowchart form in FIG. 3 A.
  • the mitral valve (MV) of FIG. 2 is depicted schematically from an inferior perspective looking up.
  • a guide catheter (404) is advanced to SAG (402) using any of the access routes (or any other suitable access routes) previously described.
  • a guidewire (406) is advanced through the lumen of guide catheter (404).
  • Guidewire (406) is advanced beyond the distal end (408) of guide catheter (404), so that guidewire (406) extends further along SAG (402) than guide catheter (404), as shown in FIG. 4B.
  • Tunnel catheter (410) is advanced through guide catheter (404), over guidewire (406), which is shown in FIG. 4C.
  • Tunnel catheter (410) may be any suitable catheter, and in some instances, as discussed above, it is desirable that the tunnel catheter be pre-shaped or pre-formed at its distal end, such as the tunnel catheter illustrated in FIG. 4C. As shown there, the tunnel catheter has a pre- shaped distal portion comprising a curve. In this way, the tunnel catheter may more easily conform to the geometry of the mitral valve. It should also be understood that while one distal curve is shown, any of the catheters or guidewires described here may be pre-shaped or preformed to include any number of suitable curves. Of course, the guidewires and/or catheters described here may also be steerable.
  • the tunnel catheter may also comprise an expandable member configured to stabilize the catheter with respect to the SAG.
  • the expandable member may be configured to engage against a first portion of tissue in order to stabilize the catheter with respect to a second portion of tissue.
  • the expandable member may be any suitable expandable member.
  • it may be a low-pressure balloon (1300), as shown in FIG. 13 A.
  • the low-pressure balloon may be made of a compliant material such as silicone, urethane, natural latex, polyisoprene or other rubbers or rubber copolymers/blends (e.g., styrenic block copolymers, polyolefin blends, polyurethane alloys, etc.), combinations or blends thereof, or other suitable compliant materials known in the art.
  • a compliant material such as silicone, urethane, natural latex, polyisoprene or other rubbers or rubber copolymers/blends (e.g., styrenic block copolymers, polyolefin blends, polyurethane alloys, etc.), combinations or blends thereof, or other suitable compliant materials known in the art.
  • an elastomeric polyurethane alloy is used.
  • the expandable member may also be made of a shape memory material such as a nickel titanium alloy, and have the shape of a wing or an arm (1302), as shown in FIG.
  • the expandable member is a low-pressure compliant balloon, inflatable with a pressurized solution (e.g., saline, or saline in combination with a contrast agent, such as a 75%/25% mixture of saline to contrast).
  • a pressurized solution e.g., saline, or saline in combination with a contrast agent, such as a 75%/25% mixture of saline to contrast.
  • the pressurized solution may be delivered to the balloon via a separate infusion lumen.
  • the infusion lumen may be concentric with the lumen through which the delivery catheters are advanced, but need not be.
  • the infusion lumen may also be located along one or both sides of the tunnel catheter.
  • the size of the expandable member will depend upon the particular body tissue to be stabilized, but in the case of SAG stabilization, a half-inch long to an inch-long balloon may be appropriate.
  • One or both sides of the balloon may be inflated, but in instances of SAG stabilization, it is more desirable to inflate only that side opposite the SAG. In this way, the tunnel catheter is pushed and held in greater apposition with the SAG.
  • the balloon may be made to inflate with variable stiffness or rigidity along its length for better apposition against certain portions of tissue.
  • tunnel catheter (410) After tunnel catheter (410) has been positioned in the SAG, guidewire (406) is withdrawn proximally as shown in FIG. 4D. After guidewire (406) has been withdrawn, a delivery catheter (412) may then be advanced through the lumen of the tunnel catheter (410). As shown in FIG. 4E, a distal portion (414) of delivery catheter (412) is advanced through an opening (416) in distal portion (411) of tunnel catheter (410). Next, and as shown in FIG. 4F, an anchor (420), which is attached to a guide element (shown in FIG. 4G as a tether (422)), is deployed from delivery catheter (412).
  • a guide element shown in FIG. 4G as a tether (422)
  • the anchor may be deployed from the delivery catheter in any suitable fashion, as will be described in more detail below when more detail is focused on the delivery catheter.
  • the anchor may be deployed using a push-pull wire (e.g., by pushing the wire distally or pulling the wire proximally), using a plunger, or may be deployed with any other suitable actuation technique.
  • anchor (420) may be attached to tether (422) by any suitable attachment method. For example, one or more knots, welded regions, and/or adhesives may be used.
  • the anchors for use with the methods and devices described here may be any suitable anchor.
  • the anchors may be made of any suitable material, may be any suitable size, and may be of any suitable shape.
  • the anchors may be made of one material or more than one material.
  • Examples of anchor materials include super-elastic or shape memory materials, such as nickel-titanium alloys and spring stainless steel.
  • Examples of anchor shapes include T- tags, rivets, staples, hooks (e.g., C-shaped or semicircular hooks, curved hooks of other shapes, straight hooks, barbed hooks), multiple looped anchors, and clips.
  • the anchors may be configured to self-expand and self-secure into tissue, but need not be configured in such a fashion.
  • a single guide element can be used to deliver and deploy multiple anchors having different shapes.
  • a single guide element can be used in the delivery and deployment of multiple anchors having different sizes.
  • suitable anchors are described in more detail, for example, in U.S. Pat. Appl. Serial No. 11/202,474, which is hereby incorporated by reference in its entirety.
  • Anchor (420), shown in FIG. 4F, self-expands as it exits delivery catheter (412) and self-secures into a region of the mitral valve annulus (AN). It should be understood that the anchors may be deployed into the annular tissue directly, or slightly below the annular tissue in the vicinity of the SAG.
  • FIG. 4G shows anchor (420), attached to tether (422) and secured to the mitral valve annulus (AN).
  • tunnel catheter (410) is now moved to a different location or position in the SAG, and a second delivery catheter (424) is advanced through the lumen of tunnel catheter (410), over tether (422), as shown in FIG. 41.
  • FIGS. 5A-5D show a method that includes using a lasso to thread a tether into a delivery catheter, and to slidably engage the tether with an anchor.
  • lasso the amount of time it takes to thread the tether into the delivery catheter and anchor can be reduced.
  • an anchor (504) is pre-loaded into a lumen (506) of a delivery catheter (502), and the proximal end (508) of a tether (500) is in the proximity of delivery catheter (502).
  • a lasso (510) is introduced into lumen (506). Lasso (510) is threaded through an eyelet (512) of anchor (504), and is used to engage tether (500), as shown in FIG. 5C.
  • FIG. 5D lasso (510) is withdrawn proximally, thereby pulling tether (500) through eyelet (512).
  • lasso (510) includes a wire portion (514) and a loop (516) at the distal end (518) of the wire portion. While loop (516) is shown as generally rounded in shape, in some variations, a lasso can include a loop having a different shape.
  • FIGS. 6A-6F show lassos having differently shaped loops. More specifically, FIG. 6A shows a lasso (600) with a substantially symmetrical round loop (602), FIG. 6B shows a lasso (610) with an asymmetrical round loop (612), FIG. 6C shows a lasso (620) with a square loop (622), FIG.
  • a lasso may include an open guide element- engaging structure, such as a hook.
  • FIG. 6F shows a lasso (650) with a hook (652) at one end that can be used to engage a guide element.
  • the shape of a lasso's guide element- engaging structure may be selected based on the configuration of the catheter through which the lasso is being threaded, and/or the type of guide element that is being threaded.
  • a lasso can be formed of, for example, a wire including one or more metals, metal alloys (e.g., nickel-titanium alloys), and/or polymers.
  • the wire can have a circular cross-section or a non-circular cross-section.
  • the lasso's guide element-engaging structure and wire portion may be formed from the same material or different materials.
  • the guide element-engaging structure is integrally formed with the wire portion.
  • the guide element-engaging structure is attached (e.g., welded) to the wire portion.
  • the lasso or a portion of the lasso (e.g., the loop) can be relatively flexible.
  • a lasso may be formed of a wire that is covered with a sheath, such as a polymer sheath, and/or a coating, such as a polymer coating. The presence of the sheath or coating may enhance the passage of the lasso through a delivery catheter lumen.
  • FIGS. 5A-5D show a method that includes using a lasso to thread a tether through a delivery catheter and an anchor
  • the method can also be used to thread guide elements, such as tethers, through other types of catheters (e.g., guide catheters, sheaths, drug delivery catheters, therapeutic catheters, locking catheters, diagnostic catheters, tool catheters, cutting catheters) and/or implants.
  • catheters e.g., guide catheters, sheaths, drug delivery catheters, therapeutic catheters, locking catheters, diagnostic catheters, tool catheters, cutting catheters
  • FIGS. 7 A and 7B show a locking catheter (700) including a tubular member (702) having a wall (712) with four openings (704, 706, 708, and 710) formed in it.
  • Locking catheters may be used to maintain tension in a guide element, such as a tether, once the guide element has been cinched (as described in further detail below), and to stabilize the guide element for cutting.
  • a tether (714) has been threaded into locking catheter (700), through holes (704, 706, 708, and 710).
  • the tether may be threaded into the locking catheter using, for example, a lasso, such as one of the lassos described above.
  • the lasso may have a relatively flexible loop which may enhance the maneuverability of the lasso through the holes in the locking catheter.
  • locking catheter (700) is shown as including four holes through which tether (714) is threaded
  • locking catheters can include other numbers of holes.
  • some variations of locking catheters may include fewer holes (e.g., two holes), while other variations of locking catheters may include more holes (e.g., six holes, eight holes, etc.).
  • the likelihood of movement by a guide element that is threaded through the holes may decrease.
  • a threading device such as a threading rod
  • the guide element may be threaded around a groove in the threading rod, and/or may be threaded through one or more holes and/or lumens in the threading rod.
  • the threading rod can provide support to the guide element, thereby making it easier to thread the guide element into the catheter. This, in turn, can reduce the total guide element-threading time. Threading devices are described, for example, in U.S. Pat. Appl. Serial No.
  • delivery catheter (424) is advanced through opening (416) in distal portion (411) of tunnel catheter (410), and is used to deploy anchor (426).
  • FIG. 8B shows a cross-sectional view of tunnel catheter (410), straightened to show its dimensions.
  • Opening (416) which is formed in a wall (450) of tunnel catheter (410), can be circular or non-circular.
  • opening (416) has a dimension (D) which may be a length, a width, or a diameter of the opening. In some variations, such as when dimension (D) is a width of the opening, dimension (D) may be from about 0.08 inch to about 0.09 inch. In certain variations, such as when opening (416) is circular and dimension (D) is a diameter of the opening, dimension (D) may be from about 0.09 inch to about 0.15 inch.
  • dimension (D) when dimension (D) is a length of the opening, dimension (D) may be from about 0.15 inch to about 0.2 inch.
  • Opening (416) may be formed in wall (450) using, any suitable technique, for example, with use of a laser.
  • tunnel catheter (410) has an inner diameter (IDl), an outer diameter (ODl), and a length (Ll).
  • Length (Ll) may measure, for example, from about 46 inches to about 48 inches.
  • inner diameter (IDl) may be from about 0.085 inch to about 0.1 inch.
  • Inner diameter (IDl) may be selected, for example, based on the dimensions of delivery catheter (424). As an example, if delivery catheter (424) has a relatively large outer diameter, then inner diameter (IDl) may also be relatively large, to provide for relatively rapid advancement of delivery catheter (424) through tunnel catheter (410).
  • outer diameter (ODl) may be from about 0.135 inch to about 0.15 inch. Outer diameter (ODl) may be selected, for example, based on the planned path for advancement of tunnel catheter (410) to the target tissue.
  • Tunnel catheter (410) can be formed of any of a number of different materials.
  • suitable materials include polymers, such as polyether-block co- polyamide polymers, copolyester elastomers, thermoset polymers, polyolefins (e.g., polypropylene or polyethylene, including high-density polyethylene and low-density polyethylene), polytetrafluoroethylene, ethylene vinyl acetate, polyamides, polyimides, polyurethanes, polyvinyl chloride (PVC, fluoropolymers (e.g., fluorinated ethylene propylene, perfluoroalkoxy (PFA) polymer, polyvinylidenefluoride, etc.), polyetheretherketones (PEEKs), and silicones.
  • PVC polyvinyl chloride
  • fluoropolymers e.g., fluorinated ethylene propylene, perfluoroalkoxy (PFA) polymer, polyvinylidenefluoride,
  • tunnel catheter (410) examples include Nylon 6 (e.g., Zytel ® HTN high performance polyamides from DuPontTM), Nylon 11 (e.g., Rilsan ® B polyamides from Arkema Inc.), and Nylon 12 (e.g., Grilamid ® polyamides from EMS-Grivory, Rilsan ® A polyamides from Arkema Inc., and Vestamid ® polyamides from Degussa Corp.).
  • tunnel catheter (410) may be formed of multiple polymers.
  • tunnel catheter (410) may be formed of a blend of different polymers, such as a blend of high-density polyethylene and low-density polyethylene.
  • tunnel catheters While wall (450) of tunnel catheter (410) is formed of a single layer, some variations of tunnel catheters may include walls having multiple layers (e.g., two layers, three layers). Furthermore, some variations of tunnel catheters may include at least two sections that are formed of different materials and/or that include different numbers of layers. Additionally, certain variations of tunnel catheters may include multiple (e.g., two, three) lumens. The lumens may, for example, be lined and/or reinforced (e.g., with braiding).
  • FIGS. 14A and 14B shows a tunnel catheter (1400) having multiple lumens.
  • tunnel catheter (1400) includes a body (1402) having a proximal section (1420), a transition section (1430), and a distal section (1440), and defining a primary lumen (1404) and a secondary lumen (1406).
  • primary lumen (1404) may be used to advance a delivery catheter to a target tissue
  • secondary lumen (1406) may be used as an inflation lumen.
  • secondary lumen (1406) may be injected with a mix of 25% contrast agent and 75% heparinized saline to inflate a balloon carried by the tunnel catheter.
  • Primary lumen (1404) is lined with a liner (1408) including a braided reinforcement (1410), and secondary lumen (1406) is similarly lined with a liner (1412) including a braided reinforcement (1414).
  • Body (1402) may be formed of one or more materials, such as one or more polymers.
  • proximal section (1420) of body (1402) may be formed of a blend of high-density polyethylene (HDPE) and low-density polyethylene (LDPE)
  • transition section (1430) of body (1402) may be formed of DuPontTM 20 low-density polyethylene (from DuPontTM)
  • distal section (1440) may be formed of Elvax 450 ethylene vinyl acetate (from DuPontTM).
  • proximal section (1420) may be about 28 inches long
  • transition section (1430) may be about eight inches long
  • distal section (1440) may be about ten inches long.
  • other lengths may be used for the proximal, transition, and distal sections.
  • Liner (1408) may be formed of high-density polyethylene or polytetrafluoroethylene (e.g., etched polytetrafluoroethylene), and liner (1412) may be formed of a flattened polyimide.
  • Braided reinforcements (1410) and (1414) may be formed of the same material or different materials.
  • An example of a material that may be suitable for one or both of the braided reinforcements is stainless steel, such as 304V stainless steel.
  • FIGS. 8A and 8B show one variation of a tunnel catheter
  • FIG. 9 shows a tunnel catheter (900), where a delivery catheter (902) is advanced out and through the distal end (904) of tunnel catheter (900).
  • FIG. 8C provides a cross-sectional view of delivery catheter (424), straightened to show its dimensions.
  • delivery catheter (424) has an inner diameter (ID2), an outer diameter (OD2), and a length (L2).
  • Length (L2) may be, for example, from about 120 centimeters to about 150 centimeters.
  • inner diameter (ID2) may be from about 0.045 inch to about 0.06 inch.
  • Inner diameter (ID2) can be selected, for example, based on the sizes and/or types of anchors being deployed from the delivery catheter.
  • outer diameter (OD2) may be from about 0.07 inch to about 0.095 inch.
  • Delivery catheter (424) can be formed of any of a number of different materials. Examples of suitable materials include polymers, such as the polymers described above with reference to tunnel catheter (410), metals (e.g., platinum, gold), metal alloys (e.g., nickel-titanium alloys such as Nitinol), and combinations of these materials. Delivery catheter (424) may be formed of some or all of the same materials as tunnel catheter (410), or may be formed of different materials from tunnel catheter (410). While delivery catheter (424) is shown as including a wall (425) that is formed of one layer, some variations of delivery catheters may include walls that are formed of multiple layers. Furthermore, delivery catheters may include at least two sections that are formed of different materials and/or that include different numbers of layers.
  • suitable materials include polymers, such as the polymers described above with reference to tunnel catheter (410), metals (e.g., platinum, gold), metal alloys (e.g., nickel-titanium alloys such as Nitinol), and combinations of these materials. Delivery catheter (
  • FIG. 8C shows one variation of a delivery catheter
  • a delivery catheter can have one lumen or multiple (e.g., two, three) lumens.
  • one section of a delivery catheter can have fewer lumens than another section of the delivery catheter.
  • a distal section of a delivery catheter may have one lumen, while a proximal section of the delivery catheter may have two or three lumens.
  • the lumens in a delivery catheter may be, for example, guide element lumens and/or infusion lumens (e.g., for the infusion of one or more therapeutic agents into a target tissue).
  • a delivery catheter may include a generally tubular member and a lumen formed on a surface of the generally tubular member.
  • the lumens in a delivery catheter may extend along the length of the delivery catheter, may be shorter than the delivery catheter, or may be a combination of the two.
  • a lumen may be located only in a distal section of a delivery catheter, or only in a proximal section of a delivery catheter.
  • certain variations of delivery catheters, or other types of catheters may include other structures through which a guide element can be threaded.
  • some variations of delivery catheters may include slotted regions on their outer surfaces. The slotted regions may be used, for example, to thread the delivery catheters over a guide element.
  • FIGS. 12A-12D show different detailed views of a variation of a delivery catheter (1200) that can be used to deliver one or more anchors to a target site.
  • delivery catheter (1200) has a distal region (1204) including a tip (1202), an anchor- holding region (1206) including a primary lumen (1208), an intermediate region (1210) including both primary lumen (1208) and a secondary lumen (1212), and a proximal region (1214) including primary lumen (1208).
  • An anchor (1216) is disposed within primary lumen (1208), in the anchor-holding region (1206). While only one anchor is shown in the anchor- holding region, some variations of delivery catheters may include an anchor-holding region that is adapted to hold multiple anchors.
  • FIGS. 12A-12D depict anchors adapted to be deployed from the distal end of the delivery catheter, it should be understood that the anchors may be deployed from any suitable region of the delivery catheter, as desirable. For example, if desirable, the anchor may be delivered out of a side port or hole on the delivery catheter.
  • a tether (1218) is threaded into a slot (1219) of tip (1202) (shown in FIGS. 12C and 12D), and through an eyelet (1226) of anchor (1216).
  • the tether After extending through the eyelet, the tether exits primary lumen (1208), and extends along an exterior surface (1221) of delivery catheter (1200) for the remainder of the length of the anchor- holding region, as shown in FIG. 12C. The tether then enters secondary lumen (1212), and extends through the length of the secondary lumen, exiting the secondary lumen at an end of distal region (1214).
  • An actuator (1220) is slidably disposed within primary lumen (1208), and can be used to deploy anchor (1216).
  • the actuator is in the form of a pushable generally tubular member, although other forms of actuators may be used. For example, in some variations, a solid rod may be used as an actuator.
  • a retrieval suture (1224) is slidably disposed within actuator (1220), and extends past the distal end (1222) of the actuator.
  • the retrieval suture loops through eyelet (1226) of anchor (1216), so that it is engaged with anchor (1216). In this way, anchors that have been misfired or misplaced may be retrieved proximally within delivery catheter (1200) for redeployment.
  • the retrieval suture is also, of course, capable of being disengaged from anchor (1216) after appropriate placement of the anchor.
  • the retrieval suture may be disengaged from the anchor by pulling on the proximal end of the retrieval suture and withdrawing the retrieval suture from the anchor eyelet and the catheter.
  • Retrieval suture (1224) may be formed of, for example, any of the tether materials described above. Furthermore, while a delivery catheter including a retrieval suture has been described, in some variations, a delivery catheter may not include a retrieval suture, or may include multiple retrieval sutures.
  • anchor (426) self-expands and self- secures to tissue in the region of the mitral valve annulus (AN).
  • anchor (426) self-secures to a different region of the mitral valve annulus from anchor (420).
  • FIG. 4J shows that while anchor (420) is fixedly attached to tether (422), anchor (426) is slidably coupled to tether (422). More specifically, anchor (420) includes an eyelet (438) that is fixedly attached to the tether at an attachment point (440), and anchor (426) includes an eyelet (436) through which the tether is threaded. The threading of the tether through eyelet (436) causes anchor (426) to be slidably engaged with the tether. Thus, if the tether is cinched, then the tether will slide through eyelet (436). Tether (422) can be threaded through multiple anchors in this manner.
  • the method described with reference to FIGS. 4A-4I can be repeated as desired to deploy multiple (e.g., at least two, at least three) anchors that can self- secure to various regions of the mitral valve annulus (AN).
  • multiple anchors e.g., at least two, at least three
  • five different delivery catheters can be successively advanced over a single tether to deploy five anchors into different regions of the mitral valve annulus.
  • eight anchors can be deployed into the mitral valve annulus, along an arc of about 240°. Again, the deployed anchors can be uniformly spaced apart, or can have varying amounts of space between them.
  • tether (422) can be cinched, thereby pulling the anchors closer together, and reducing the circumference of the mitral valve annulus.
  • Tether (422) can be terminated after the desired extent of reduction has been achieved (e.g., as determined by ultrasound and fluoroscopy).
  • a clip can be attached to tether (422) proximal to the proximal-most anchor, to maintain the tension of tether (422) between the anchors.
  • Tether (422) can then be cut proximal to the clip.
  • attachment and cutting can be achieved using a termination device, such as a termination catheter.
  • one or more cutting and/or locking catheters can be used to maintain the tension in a cinched guide element and to remove the unused portion of the guide element, after cinching has been completed. Termination devices are described, for example, in U.S. Pat. Appl. Serial Nos. 11/232,190 and 11/270,034, both of which are hereby incorporated by reference in their entirety.
  • Some methods of terminating tether (422) may include withdrawing tunnel catheter (410) from guide catheter (404) prior to advancing a termination catheter over tether (422) to the proximal-most anchor. The termination catheter may then be used for attachment and cutting of tether (422).
  • Other methods may include first attaching a clip to tether (422) proximal to the proximal-most anchor to maintain the tension in tether (422), and then withdrawing tunnel catheter (410) from guide catheter (404).
  • a method may include attaching tether (422) to the proximal-most secured anchor, and then cutting tether (422) proximal to the anchor to which tether (422) has been attached.
  • Tether (422) can be attached to the proximal-most anchor using, for example, one or more adhesives, and/or one or more knotting, crimping, and/or tying techniques. While threading, cinching, and termination techniques have been described with respect to a tether, these techniques may be used with other guide elements as well.
  • a guide element can be threaded through a termination catheter in any of a number of different ways.
  • FIGS. 10A-10E show examples of different routings of tethers through locking catheters
  • FIGS. 1 IA-11C show examples of different routings of tethers through cutting catheters.
  • a locking catheter (1000) includes a tip (1002) and a shaft (1004).
  • a tether (1006) is threaded through four openings in the tip, so that the locking catheter secures the tether, thereby maintaining the tension in the tether. While tether (1006) is threaded through four openings in tip (1002), guide elements can be threaded through different numbers of openings in a catheter tip.
  • FIG. 1OB shows a locking catheter (1014) including a tip (1015), and a tether (1016) that has been threaded through two openings in the tip of the locking catheter.
  • a tether (1018) is threaded through three openings in a tip (1022) of a locking catheter (1024), and also is threaded into the shaft (1026) of the locking catheter.
  • the tether eventually exits the shaft through an opening in the shaft.
  • FIG. 1OD shows a tether (1030) that is threaded into the distal end (1031) of the tip (1034) of a locking catheter (1036), and that extends through the shaft (1040) of the locking catheter, exiting through an opening in the shaft.
  • Guide elements can extend through varying lengths of a shaft of a delivery catheter. For example, while the tether in FIG. 1 OD extends through a relatively short length of the catheter shaft, FIG.
  • 1 OE shows a tether that extends through a relatively long length of a catheter shaft.
  • a tether (1042) is threaded into an opening in a tip (1046) of a locking catheter (1048), and extends through almost the entire length of the shaft (1050) of the locking catheter.
  • Tether (1042) exits the shaft through an opening in the proximal end (1051) of the shaft.
  • FIG. 1 IA shows a cutting catheter (1100) including a tip portion (1102) and a shaft portion (1104).
  • a tether (1106) is threaded through two openings in tip portion (1102).
  • a cutting element (1108) is disposed within a lumen of shaft portion (1104), and can be used to cut the tether (e.g., after a cinching procedure has taken place).
  • FIG. 1 IB shows a different routing configuration for a tether that is threaded through a cutting catheter. As shown in FIG.
  • a cutting catheter (1110) includes a tip portion (1112) and a shaft portion (1114) containing a cutting element (1118).
  • a tether (1116) is threaded into tip portion (1112) at its distal end (1119), and through three openings in the tip portion.
  • a cutting catheter (1120) includes a tip portion (1122) and a shaft portion (1124).
  • a tether (1126) is threaded into the tip portion (1122) at its distal end (1127), and exits the tip portion through an opening that is proximal to distal end (1127).
  • a cutting element (1128) is disposed within shaft portion (1124).
  • Guide elements can be threaded through different numbers of holes in cutting catheters and/or through different locations in cutting catheters. All of the described threading variations are merely illustrative examples of suitable threading techniques.
  • routing configurations for guide elements through locking catheters and cutting catheters have been shown, the routing configurations may be used in other types of catheters as well. Additionally, other routing configurations may be used to thread a guide element through a catheter. As an example, in some variations, a guide element may not be threaded through a tip of a catheter.
  • an implant may include one or more anchors, may include a lead or electrode (e.g., a pacing electrode, a diagnostic electrode, an active electrode), or may include any other suitable implant.
  • an implant may include a fabric implant, or an annuloplasty ring, alone or in combination with one or more anchors. Additional examples of implants include implants that deliver therapy, such as drug-delivery implants, and implants that telemetry information, such as information about the conditions of the target site. For example, implants may be used to deliver growth factors and/or genetic regenerative factors. Implants are described, for example, in U.S. Pat. App.

Abstract

Methods and devices for successively advancing a plurality of catheters over a guide element to a body tissue are described. In some of the methods, the guide element may be attached to the body tissue, which may be accessible minimally invasively. In certain variations, the guide element may not be detached from the body tissue after the catheters have been advanced over the guide element. The methods may further comprise deploying at least one implant from at least one of the plurality of catheters. In some variations, a method may comprise advancing a first delivery catheter to a first region of a body tissue, deploying a first anchor from the first delivery catheter, where the first anchor is attached to a guide element, proximally withdrawing the first delivery catheter, advancing a second delivery catheter over the guide element, and deploying a second anchor from the second delivery catheter.

Description

METHODS AND DEVICES FOR CATHETER ADVANCEMENT AND DELIVERY OF
SUBSTANCES THERETHROUGH
TECHNICAL FIELD
[0001] The methods and devices described herein relate generally to the field of advancement of catheters over a guide element and delivery of substances through those catheters (e.g., implants, such as anchors or leads, or drugs). More specifically, the methods described here are in the field of successive advancement of a plurality of catheters over a guide element where the guide element is attached to a body tissue that is accessible minimally invasively, or where the guide clement if left behind as an implant. The methods and devices described here may have particular utility in the area of mitral valve repair.
BACKGROUND
[0002] Advances have been made in the techniques and tools used in minimally invasive surgery. For example, catheters are now routinely used to access various body tissues (e.g., organs such as the heart, and vessels, such as coronary arteries). Procedures that require prolonged access to the body tissue and exchange of various tools are often lengthy due to the number of different tools that must be passed to the target site from a proximal position outside the patient's body. Methods of rapid-exchange and over-the-wire catheter systems have been developed to try to compensate for and reduce surgery times.
[0003] Rapid-exchange catheters generally include a guidewire lumen that extends for only a portion of the length of the catheter shaft. A rapid-exchange catheter may be relatively easily threaded over a guidewire, delivered to a target site, and withdrawn from the target site. Because rapid-exchange catheters do not need to be threaded over the entire length of a guidewire, rapid-exchange catheters may be relatively short in length. In some variations, a rapid-exchange catheter may be shorter in length than the guidewire over which the rapid- exchange catheter is advanced. The guidewire, in turn, may also be relatively short in length. After being withdrawn from a target site, a rapid-exchange catheter can be removed from the guidewire over which it was threaded, and exchanged with another rapid-exchange catheter, which, in turn, can be delivered to the target site over the guidewire. Some methods of removing a rapid-exchange catheter from a guidewire include withdrawing the rapid-exchange catheter over the guidewire. Other methods include using a rapid-exchange catheter with a perforated sheath, and splitting the sheath open at its perforations to remove the rapid-exchange catheter from the guidewire. The relative ease with which rapid-exchange catheters can be exchanged over a guidewire, as well as the relatively short length of rapid-exchange catheters and their guidewires, may result in reduced procedure time when such catheters are used. Additionally, rapid-exchange procedures can allow for different types of catheters (e.g., catheters having balloons of different sizes or catheters carrying different therapeutic agents) to be efficiently delivered to a target site in one procedure. Furthermore, the use of rapid-exchange catheters in a procedure may result in a reduction in the number of operations required to complete the procedure.
[0004] Over-the-wire catheters generally include a guidewire lumen that extends along the entire length of the catheter shaft. Over-the-wire catheters may be used, for example, in peripheral procedures, such as balloon angioplasty procedures. An over-the-wire catheter may be relatively easily tracked over a guidewire and delivered to a target site. Once the over- the-wire catheter has been used to perform a procedure at the target site, it may be withdrawn over the guidewire and removed from the subject.
[0005] In instances in which multiple catheters must be delivered to a target body tissue, rapid-exchange and over-the wire techniques are particularly desirable, as they may result in reduced procedure time and/or highly accurate catheter delivery. Accordingly, additional methods and devices for advancing a plurality of catheters to a target body tissue would be desirable. Similarly, catheters configured to be advanced quickly and successively to a target body tissue would also be desirable.
BRIEF SUMMARY
[0006] Described here are methods and devices for successively advancing a plurality of catheters over a guide element to a target body tissue. Some of the methods described here generally comprise successively advancing a plurality of catheters over a guide element, wherein the guide element is attached to a body tissue. The body tissue may be accessible minimally invasively. In certain variations, the guide element may not be detached from the body tissue after the catheters have been advanced over the guide element. The methods may further comprise deploying at least one implant from at least one of the plurality of catheters. The implant may be any suitable implant. For example, it may be an anchor, a lead or electrode, or any other implant capable of fixedly securing the tether to the body tissue. In some variations, the implant is an anchor, and the anchor is configured to self-expand and self-secure into a region of the body tissue.
[0007] The body tissue may be any body tissue that is accessible minimally invasively, and in some variations, the body tissue comprises heart tissue (e.g., mitral valve tissue). In these variations, the methods may be used to deploy a series of anchors (that are carried in one or more catheters) in the region of a heart valve annulus of a subject in order to reduce mitral valve regurgitation.
[0008] Any suitable number and type of catheter may be used and advanced over the guide element. For example, the catheter may be a guide catheter, a sheath, a drug delivery catheter, a therapeutic catheter, a termination catheter, a cutting catheter, a locking catheter, a diagnostic catheter, a tool catheter, or any other suitable catheter. Some methods may include advancing one type of catheter over the guide element, and then advancing a different type of catheter over the guide element.
[0009] Other methods described here comprise advancing a first delivery catheter to a first region of a body tissue, deploying a first anchor from the first delivery catheter, wherein the first anchor is attached to a guide element, proximally withdrawing the first delivery catheter, advancing a second delivery catheter over the guide element, and deploying a second anchor from the second delivery catheter. The second anchor may be slidably coupled to the guide element, so that the guide element will not be held rigidly in place at the site of the second anchor deployment. The anchors may have eyelets through which the guide element may be slidably disposed. The guide element may be slidably coupled to the anchor with the use of a lasso prior to insertion in the delivery catheter.
[0010] The first and second anchors can be deployed to the same region or different regions of the body tissue, and any number of anchors may be deployed as desirable. In some variations, the anchors self-expand and self-secure into different regions of the body tissue. As with the methods described above, any number or type of catheters may be used, and in some variations, advancing the first delivery catheter to the first region of the body tissue comprises advancing the first delivery catheter through a tunnel catheter. The tunnel catheter may have an opening positioned along its side wall, or otherwise positioned proximally of its distal tip, and in some variations, the first delivery catheter is advanced through the opening.
[0011] Any of the catheters. described here may be pre-shaped or pre-formed in some fashion or in a particular geometry. For example, in some instances, it may be desirable for the catheter to include one or more curves to better conform to the target anatomy. In some of the variations described here, the distal portion of the tunnel catheter is pre-shaped to include at least one curve. The catheters may also have any number of suitable lumens, such as lumens that are configured to allow passage of a guide element therethrough. In some variations, a catheter described here may have a lumen that is located in either a proximal section or a distal section of the catheter, but not in both sections.
[0012] Similarly, the guide element may comprise or be made from any suitable material. For example, the guide element may be made from an artificial or natural suture material, or it may be made from a metal or shape memory alloy. The guide element may be made from one or more absorbable materials, and/or one or more non-absorbable materials. In some variations, the guide element is made from polyester impregnated with polytetrafluoroethylene. In certain variations, the guide element is a tether (e.g., a suture). In some variations, the guide element may be in the form of a wire. The guide element may be braided or woven, and/or may include multiple different layers.
[0013] Again, these methods may deploy any number of anchors, and in some variations, the anchors are deployed into heart tissue, e.g., heart tissue in the region of the mitral valve. When multiple anchors are deployed to a region of the mitral valve annulus, the guide element the delivery catheters were advanced over, may be cinched, or pulled proximally. The result may be a geometric change in at least one of the mitral valve annulus and the tissue surrounding the mitral valve annulus, a reduction in the circumference of the mitral valve annulus, enhancement of mitral valve leaflet apposition, and/or a reduction in mitral valve regurgitation.
[0014] Devices for stabilizing a catheter with respect to a body tissue are also described. In general, these devices comprise a catheter having an expandable member configured to engage against a first portion of tissue in order to stabilize the catheter with respect to a second portion of tissue. The expandable member may be any member suitable for providing such stabilization. For example, the expandable member may be a low-pressure inflatable balloon made of a compliant material, or the expandable member may be made of a shape memory material, such as a nickel titanium alloy basket or wing. In some variations, a low-pressure balloon is used and only a portion of the balloon is configured to inflate.
[0015] Catheters for advancement along a guide element are also described here. In general, the catheters comprise at least one lumen. In some variations, the catheters comprise a first and a second lumen where the first and second lumens are positioned adjacent to one another, where at least a portion of the first and second lumens are configured to allow the passage of the guide element therethrough, and where the second lumen is accessible from the first lumen. The catheter may be any suitable catheter and may have any number of desirable functions (e.g., the catheter may be a cutting catheter, a termination catheter, a device delivery catheter, a drug delivery catheter, a therapeutic catheter, a diagnostic catheter, a tool catheter, etc.). For example, the catheter may be a therapeutic catheter that is configured for use in tissue altering therapy, such as ablation. In some variations, the catheter is a device delivery catheter used for electrical pacing or for delivery of at least one anchor. In these variations, the anchor is typically positioned in the first lumen.
BRIEF DESCRIPTION OF THE DRAWINGS
[0016] FIG. 1 is a cross-sectional view of a heart.
[0017] FIG. 2 is a cross-sectional view of a portion of a heart.
[0018] FIG. 3A is a flowchart representation of a method for delivering at least two anchors into a region of a heart valve annulus.
[0019] FIGS. 3B-3E schematically depict variations of anchor deployment.
[0020] FIGS. 4A-4I provide a detailed depiction of a method for advancing at least two delivery catheters to the sub-annular groove ("SAG") of a heart valve to deliver at least two anchors into a region of a heart valve annulus.
[0021] FIG. 4J is an enlarged view of region 4J of FIG. 41. [0022] FIGS. 5A-5D illustrate a method for engaging a guide element with an anchor.
[0023] FIGS. 6A-6F depict different variations of lassos.
[0024] FIG. 7 A is a perspective view of a locking catheter.
[0025] FIG. 7B is a cross-sectional view of the locking catheter of FIG. 7 A, taken along line 7B-7B.
[0026] FIG. 8 A is a cross-sectional view of a portion of a tunnel catheter through which a delivery catheter is advanced, FIG. 8B is a side cross-sectional view of the tunnel catheter of FIG. 8 A, and FIG. 8C is a side cross-sectional view of the tunnel catheter of FIG. 8A.
[0027] FIG. 9 is a cross-sectional view of a portion of a tunnel catheter through which a delivery catheter is advanced.
[0028] FIGS. 10A- 1OE are side views of different routing configurations of guide elements in locking catheters.
[0029] FIGS. 1 IA-11C are side views of different routing configurations of guide elements in cutting catheters.
[0030] FIG. 12A is a perspective view of a delivery catheter, FIG. 12B is a front view of the delivery catheter of FIG. 12 A, and FIGS. 12C and 12D are side and bottom views, respectively, of a portion of the delivery catheter of FIG. 12 A.
[0031] FIGS. 13A-13C depict various expandable members that may be used to help stabilize a catheter in the SAG.
[0032] FIG. 14A is a perspective view of a tunnel catheter.
[0033] FIG. 14B is a cross-sectional view of the tunnel catheter of FIG. 14A, taken along line 14B-14B. DETAILED DESCRIPTION
[0034] Described here are methods for successively advancing a plurality of catheters over a guide element, and method and devices for delivering anchors to a region of a body tissue. It should be understood from the outset that while methods of advancing a plurality of catheters to heart valve tissue are described in detail here, the methods may be used, and are contemplated for use, with any body tissue that may be accessed minimally invasively. Examples of body tissue that may be accessed minimally invasively include body tissue that may be accessed percutaneously (e.g., intravascularly), laparoscopically, endoscopically, robotically, and/or through one or more airways. Thus, the detailed description provided here of how these methods and devices are used with respect to the mitral valve heart anatomy simply represents one illustrative variation of how these methods and devices may be used. For example, the methods may be applied to the coronary sinus, the tricuspid valve, the left and/or right ventricles, and/or one or more veins. In some variations, the methods may be used with the bladder, the urethra, the lungs, the stomach, the liver, the kidneys, the gallbladder, and/or in peripheral applications (e.g., in the legs). In certain variations, the methods may be used in gastrointestinal applications or in transbrachial applications. Furthermore, the methods may be used to deliver therapy, such as tissue modification, electrical pacing, or an implant. In some variations, the guide element may be used to facilitate delivery of one or more tools to a target site. In certain variations, the guide element may be used to facilitate a robotic procedure, such as the robotic delivery of one or more tools to a target site.
[0035] In general, the methods of advancing a plurality of catheters over a guide element comprise advancing multiple catheters over a guide element, where the guide element is attached to body tissue that is accessible minimally invasively. Alternatively or additionally, the methods may comprise deploying at least one implant from one of the catheters. The implant may be any suitable or desirable implant. For example, the implant may be a lead or electrode, an anchor, or any other implant. The implant may also be of any suitable shape and size. When anchors are used, they may be configured to self-expand and self-secure into the tissue. Suitable anchors and guide elements will be described in more detail below. Similarly, any suitable catheter may be used and advanced over the guide element. For example, the catheter may be a guide catheter, a sheath, a drug delivery catheter, a therapeutic catheter, a termination catheter, a locking catheter, a cutting catheter, a diagnostic catheter, a tool catheter, or any other suitable catheter. These catheters will also be described in more detail below.
[0036] Other methods described here employ the use of various delivery catheters. For example, these methods generally comprise advancing a first delivery catheter to a first region of a body tissue, deploying a first anchor from the first delivery catheter, wherein the first anchor is attached to a guide element, proximally withdrawing the first delivery catheter, advancing a second delivery catheter over the guide element, and deploying a second anchor from the second delivery catheter.
[0037] These methods may deploy any number of anchors, and in some variations, the anchors are deployed into heart tissue, e.g., tissue in the region of the mitral valve. When multiple anchors are deployed to a region of the mitral valve annulus, the guide element the delivery catheters were advanced over, may be cinched, or pulled proximally to reduce the circumference of the mitral valve annulus. In this way, a mitral valve may be repaired using a relatively efficient and minimally invasive procedure. As an example, the use of a single guide element to deliver multiple delivery catheters and/or to deploy multiple anchors may result in reduced procedure time and a reduced likelihood of error in anchor placement. As another example, the use of a single anchored guide element may allow for the delivery of multiple delivery catheters and/or deployment of multiple anchors to a target site, without requiring visualization of the delivery and/or deployment. Furthermore, in some variations, the guide element may be fixedly attached or otherwise secured to a target site and used as a track for the delivery of multiple delivery catheters and/or deployment of multiple anchors to the target site, and also may be left at the target site when the procedure is finished, to serve as an implant itself.
[0038] Turning now to the figures, FIG. 1 is a cross-sectional schematic representation of a heart (100). As shown, heart (100) includes the superior vena cava (SVC), the right atrium (RA), the right ventricle (RV), the tricuspid valve leaflets (TVL), the aorta (A), the mitral valve leaflets (MVL), the left atrium (LA), and the left ventricle (LV). The tricuspid valve separates the right atrium (RA) from the right ventricle (RV), and the mitral valve separates the left atrium (LA) from the left ventricle (LV). The mitral valve has two leaflets (MVL), the anteromedial leaflet and the posterolateral leaflet. Surrounding the opening of the mitral valve is a fibrous ring known as the mitral valve annulus. A normally functioning mitral valve allows blood to flow into the left ventricle during ventricular diastole, and prevents blood from going from the ventricle to the left atrium during systole, in a retrograde fashion. A mitral valve that allows blood to flow into the left atrium is said to have regurgitation, and in instances where the regurgitation is severe, mitral valve repair may be desirable.
[0039] FIG. 2 provides a schematic cross-sectional view of a portion 200 of the mitral valve (MV) anatomy. As shown, portion (200) includes a mitral valve leaflet (MVL). The annulus (AN), which surrounds the valve, is also shown. As FIG. 2 shows, the SAG is the track defined by the joinder of the horizontal underside of the mitral valve annulus (AN) with the ventricular wall (VW). An equivalent subannular groove is positioned on the underside of the tricuspid valve, and the methods and devices described here may be used with respect to the tricuspid valve as well.
[0040] Any suitable method of accessing the SAG may be used. For example, a catheter may be inserted into the femoral artery and passed through the right atrium (RA), through the interatrial septum in the area of the foramen ovale behind the aorta (A), and into the left ventricle. Upon further advancement, the distal portion of the catheter will naturally travel under the posterolateral valve leaflet into the SAG. The catheter may be further advanced along the SAG, either partially or completely around the circumference of the valve. It is often desirable to have the catheter seated at the intersection of the mitral valve leaflets (MVL) and the ventricular wall, adjacent to, and very near the annulus from the underside. The use of a pre- shaped catheter (e.g., a catheter having a pre-shaped distal end or portion) may aid in placement by conforming to the target anatomy. While the approach described above employs access through the femoral artery, access may be obtained through other suitable vessels as well (e.g., the jugular artery).
[0041] FIG. 3 A provides a flowchart depiction of a method (300) for deploying at least two anchors in the region of a heart valve annulus. As shown there, this illustrative method comprises advancing a guide catheter to the SAG (310), advancing a guidewire through a lumen of the guide catheter (320), advancing a tunnel catheter over the guidewire (330), and proximally withdrawing the guidewire from the tunnel catheter (340). After the guidewire has been proximally withdrawn, a first delivery catheter may be advanced through the lumen of the tunnel catheter (350) and a first anchor may be deployed into a first region of the heart valve annulus (360). The first anchor is typically fixedly attached or otherwise secured to a guide element, such as a tether. In this way, after the anchor is deployed, the guide element will remain attached to the anchor and the guide element may be used as a track or monorail for the advancement of additional delivery catheters thereover.
[0042] The guide element may be made from any suitable or desirable biocompatible material. The guide element may be braided or not braided, woven or not woven, reinforced or impregnated with additional materials, or may be made of a single material or a combination of materials. For example, the guide element may be made from a suture material (e.g., absorbable suture materials such as polyglycolic acid and polydioxanone, natural fibers such as silk, and artificial fibers such as polypropylene, polyester, polyester impregnated with polytetrafluoroethylene, nylon, etc.), may be made from a metal (absorbable or non-absorbable), may be made from a metal alloy (e.g., stainless steel), may be made from a shape memory material, such as a shape memory alloy (e.g., a nickel titanium alloy), may be made from combinations thereof, or may be made from any other biocompatible material. In some variations, when pulled proximally, the guide element will cinch or reduce the circumference of the mitral valve annulus. In certain variations, the guide element may be in the form of a wire. The guide element may include multiple layers, and/or may include one or more coatings. For example, the guide element may be in the form of a polymer-coated wire. In certain variations, the guide element may be formed of a combination of one or more sutures and one or more wires. As an example, the guide element may be formed of a suture that is braided with a wire. In some variations, the guide element may be formed of one or more electrode materials. In certain variations, the guide element may be formed of one or more materials that provide for the telemetry of information (e.g., regarding the condition of the target site).
[0043] In some variations, the guide element may include one or more therapeutic agents (e.g., drugs, such as time-release drugs). As an example, the guide element may be partially or entirely coated with one or more therapeutic agents. In certain variations, the guide element may be used to deliver one or more growth factors and/or genetic regenerative factors. In some variations, the guide element may be coated with a material (e.g., a polymer) that encapsulates one or more therapeutic agents, or in which one or more therapeutic agents are embedded. The therapeutic agents may be used, for example, to treat the target site to which the guide element is fixedly attached or otherwise secured. In certain variations, the guide element may include one or more lumens through which a therapeutic agent can be delivered. [0044] After the first anchor has been deployed in the region of the heart valve annulus, the first delivery catheter is withdrawn proximally and the tunnel catheter is positioned at a different location about the SAG (370). A second delivery catheter is then advanced over the guide element through the lumen of the tunnel catheter (380). During advancement of the second delivery catheter over the guide element, the guide element may enter the second delivery catheter through an opening at its distal end, and exit the second delivery catheter through an opening in its side wall that is proximal to its distal end. Alternatively, the guide element may enter the second delivery catheter through an opening at its distal end, and exit the second delivery catheter through an opening at its proximal end. After the second delivery catheter has been advanced over the guide element through the lumen of the tunnel catheter, a second anchor is deployed into a second region of the heart valve annulus (390).
[0045] Any number of anchors may be deployed using this method with any number of suitable delivery catheters. For example, in some instances, it may be desirable to reduce the circumference of the mitral valve annulus by deploying two anchors in two different regions of the heart valve annulus, as shown by FIGS. 3B and 3C. FIGS. 3B and 3C (as well as FIGS. 3D and 3E below) depict the mitral valve (MV) of FIG. 2 schematically from an inferior perspective looking up. In FIG. 3B anchors (392) are shown deployed in the mitral valve in an anterior-posterior fashion, whereas in FIG. 3C anchors (394) are shown deployed in a transverse fashion. In other variations it may be desirable to deploy multiple sets of anchors about the mitral valve in the region of the annulus. For example, in FIG. 3D, pairs, or sets of two anchors (396) are shown deployed. It should be understood that any number of anchors, e.g., two, three, four, five, six, seven, etc. may make up a set, and that the sets need not be symmetrically or evenly spaced about the annulus as shown in FIG. 3D. Indeed, in some instances, it may be desirable to reinforce one anchor, but not others, and in these instances, there may be a combination of single and set anchor deployment. Again, the anchors (or sets of anchors) may be deployed symmetrically or evenly spaced about the annulus as shown in FIG. 3E with reference to anchors (398), but they need not be.
[0046] It should also be understood that while the method depicted in flowchart fashion in FIG. 3 A shows multiple anchors being delivered via multiple delivery catheters, other methods of delivering the anchors may be used. For example, it some instances, it may be desirable to deliver multiple anchors from a single delivery catheter as described in more detail in U.S. Pat. Appl. Serial No. 11/201,949, which is hereby incorporated by reference in its entirety. Similarly, it may be desirable to combine multiple anchor delivery and deployment via a single delivery catheter with single anchor delivery and deployment via a single delivery catheter. Ordinary artisans will choose the number and type of catheters most appropriate for their procedure and circumstances.
[0047] FIGS. 4A-4I provide a more detailed depiction of the method shown in flowchart form in FIG. 3 A. In FIGS. 4A-4I, the mitral valve (MV) of FIG. 2 is depicted schematically from an inferior perspective looking up. Referring to FIG. 4A, a guide catheter (404) is advanced to SAG (402) using any of the access routes (or any other suitable access routes) previously described. After guide catheter (404) has been positioned at the desired location in SAG (402), a guidewire (406) is advanced through the lumen of guide catheter (404). Guidewire (406) is advanced beyond the distal end (408) of guide catheter (404), so that guidewire (406) extends further along SAG (402) than guide catheter (404), as shown in FIG. 4B.
[0048] After guidewire (406) has been positioned in the SAG, a tunnel catheter (410) is advanced through guide catheter (404), over guidewire (406), which is shown in FIG. 4C. Tunnel catheter (410) may be any suitable catheter, and in some instances, as discussed above, it is desirable that the tunnel catheter be pre-shaped or pre-formed at its distal end, such as the tunnel catheter illustrated in FIG. 4C. As shown there, the tunnel catheter has a pre- shaped distal portion comprising a curve. In this way, the tunnel catheter may more easily conform to the geometry of the mitral valve. It should also be understood that while one distal curve is shown, any of the catheters or guidewires described here may be pre-shaped or preformed to include any number of suitable curves. Of course, the guidewires and/or catheters described here may also be steerable.
[0049] The tunnel catheter may also comprise an expandable member configured to stabilize the catheter with respect to the SAG. For example, the expandable member may be configured to engage against a first portion of tissue in order to stabilize the catheter with respect to a second portion of tissue. The expandable member may be any suitable expandable member. For example, it may be a low-pressure balloon (1300), as shown in FIG. 13 A. The low-pressure balloon may be made of a compliant material such as silicone, urethane, natural latex, polyisoprene or other rubbers or rubber copolymers/blends (e.g., styrenic block copolymers, polyolefin blends, polyurethane alloys, etc.), combinations or blends thereof, or other suitable compliant materials known in the art. In some variations, an elastomeric polyurethane alloy is used. The expandable member may also be made of a shape memory material such as a nickel titanium alloy, and have the shape of a wing or an arm (1302), as shown in FIG. 13B, or a basket (1304), as shown in FIG. 13C.
[0050] In some variations, the expandable member is a low-pressure compliant balloon, inflatable with a pressurized solution (e.g., saline, or saline in combination with a contrast agent, such as a 75%/25% mixture of saline to contrast). The pressurized solution may be delivered to the balloon via a separate infusion lumen. The infusion lumen may be concentric with the lumen through which the delivery catheters are advanced, but need not be. For example, the infusion lumen may also be located along one or both sides of the tunnel catheter. The size of the expandable member will depend upon the particular body tissue to be stabilized, but in the case of SAG stabilization, a half-inch long to an inch-long balloon may be appropriate. One or both sides of the balloon may be inflated, but in instances of SAG stabilization, it is more desirable to inflate only that side opposite the SAG. In this way, the tunnel catheter is pushed and held in greater apposition with the SAG. Similarly, the balloon may be made to inflate with variable stiffness or rigidity along its length for better apposition against certain portions of tissue.
[0051] After tunnel catheter (410) has been positioned in the SAG, guidewire (406) is withdrawn proximally as shown in FIG. 4D. After guidewire (406) has been withdrawn, a delivery catheter (412) may then be advanced through the lumen of the tunnel catheter (410). As shown in FIG. 4E, a distal portion (414) of delivery catheter (412) is advanced through an opening (416) in distal portion (411) of tunnel catheter (410). Next, and as shown in FIG. 4F, an anchor (420), which is attached to a guide element (shown in FIG. 4G as a tether (422)), is deployed from delivery catheter (412). The anchor may be deployed from the delivery catheter in any suitable fashion, as will be described in more detail below when more detail is focused on the delivery catheter. For example, the anchor may be deployed using a push-pull wire (e.g., by pushing the wire distally or pulling the wire proximally), using a plunger, or may be deployed with any other suitable actuation technique. Similarly, anchor (420) may be attached to tether (422) by any suitable attachment method. For example, one or more knots, welded regions, and/or adhesives may be used.
[0052] The anchors for use with the methods and devices described here may be any suitable anchor. The anchors may be made of any suitable material, may be any suitable size, and may be of any suitable shape. The anchors may be made of one material or more than one material. Examples of anchor materials include super-elastic or shape memory materials, such as nickel-titanium alloys and spring stainless steel. Examples of anchor shapes include T- tags, rivets, staples, hooks (e.g., C-shaped or semicircular hooks, curved hooks of other shapes, straight hooks, barbed hooks), multiple looped anchors, and clips. The anchors may be configured to self-expand and self-secure into tissue, but need not be configured in such a fashion. Additionally, while the delivery and deployment of multiple anchors of the same shape over a single guide element have been described, in some variations, a single guide element can be used to deliver and deploy multiple anchors having different shapes. Similarly, in certain variations, a single guide element can be used in the delivery and deployment of multiple anchors having different sizes. Illustrative examples of suitable anchors are described in more detail, for example, in U.S. Pat. Appl. Serial No. 11/202,474, which is hereby incorporated by reference in its entirety.
[0053] Anchor (420), shown in FIG. 4F, self-expands as it exits delivery catheter (412) and self-secures into a region of the mitral valve annulus (AN). It should be understood that the anchors may be deployed into the annular tissue directly, or slightly below the annular tissue in the vicinity of the SAG.
[0054] After anchor (420) has been deployed, delivery catheter (412) is proximally withdrawn. FIG. 4G shows anchor (420), attached to tether (422) and secured to the mitral valve annulus (AN). As shown in FIG. 4H, tunnel catheter (410) is now moved to a different location or position in the SAG, and a second delivery catheter (424) is advanced through the lumen of tunnel catheter (410), over tether (422), as shown in FIG. 41.
[0055] Before delivery catheter (424) is advanced through tunnel catheter (410), tether (422) is threaded into delivery catheter (424), and is slidably engaged with a second anchor (426). Any of a number of different methods can be used to thread a guide element, such as a tether, into a delivery catheter, and to engage the guide element with an anchor. For example, FIGS. 5A-5D show a method that includes using a lasso to thread a tether into a delivery catheter, and to slidably engage the tether with an anchor. By using the lasso, the amount of time it takes to thread the tether into the delivery catheter and anchor can be reduced. As shown in FIG. 5 A, an anchor (504) is pre-loaded into a lumen (506) of a delivery catheter (502), and the proximal end (508) of a tether (500) is in the proximity of delivery catheter (502). Next, and referring to FIG. 5B, a lasso (510) is introduced into lumen (506). Lasso (510) is threaded through an eyelet (512) of anchor (504), and is used to engage tether (500), as shown in FIG. 5C. Referring now to FIG. 5D, lasso (510) is withdrawn proximally, thereby pulling tether (500) through eyelet (512).
[0056] As shown in FIGS. 5B-5D, lasso (510) includes a wire portion (514) and a loop (516) at the distal end (518) of the wire portion. While loop (516) is shown as generally rounded in shape, in some variations, a lasso can include a loop having a different shape. For example, FIGS. 6A-6F show lassos having differently shaped loops. More specifically, FIG. 6A shows a lasso (600) with a substantially symmetrical round loop (602), FIG. 6B shows a lasso (610) with an asymmetrical round loop (612), FIG. 6C shows a lasso (620) with a square loop (622), FIG. 6D shows a lasso (630) with a triangular loop (632), and FIG. 6E shows a lasso (640) with a diamond-shaped loop (642). Additionally, while closed loops have been shown for engaging guide elements, in some variations, a lasso may include an open guide element- engaging structure, such as a hook. For example, FIG. 6F shows a lasso (650) with a hook (652) at one end that can be used to engage a guide element. The shape of a lasso's guide element- engaging structure may be selected based on the configuration of the catheter through which the lasso is being threaded, and/or the type of guide element that is being threaded.
[0057] A lasso can be formed of, for example, a wire including one or more metals, metal alloys (e.g., nickel-titanium alloys), and/or polymers. The wire can have a circular cross-section or a non-circular cross-section. The lasso's guide element-engaging structure and wire portion may be formed from the same material or different materials. In some variations, the guide element-engaging structure is integrally formed with the wire portion. In other variations, the guide element-engaging structure is attached (e.g., welded) to the wire portion. The lasso or a portion of the lasso (e.g., the loop) can be relatively flexible. This flexibility may help the lasso to more readily engage the guide element by allowing the lasso to flex and bend around the guide element. In certain variations, at least a portion of a lasso can be formed of a wire that is covered with a sheath, such as a polymer sheath, and/or a coating, such as a polymer coating. The presence of the sheath or coating may enhance the passage of the lasso through a delivery catheter lumen.
[0058] While FIGS. 5A-5D show a method that includes using a lasso to thread a tether through a delivery catheter and an anchor, the method can also be used to thread guide elements, such as tethers, through other types of catheters (e.g., guide catheters, sheaths, drug delivery catheters, therapeutic catheters, locking catheters, diagnostic catheters, tool catheters, cutting catheters) and/or implants.
[0059] As an example, FIGS. 7 A and 7B show a locking catheter (700) including a tubular member (702) having a wall (712) with four openings (704, 706, 708, and 710) formed in it. Locking catheters may be used to maintain tension in a guide element, such as a tether, once the guide element has been cinched (as described in further detail below), and to stabilize the guide element for cutting. In FIGS. 7 A and 7B, a tether (714) has been threaded into locking catheter (700), through holes (704, 706, 708, and 710). The tether may be threaded into the locking catheter using, for example, a lasso, such as one of the lassos described above. The lasso may have a relatively flexible loop which may enhance the maneuverability of the lasso through the holes in the locking catheter. While locking catheter (700) is shown as including four holes through which tether (714) is threaded, locking catheters can include other numbers of holes. For example, some variations of locking catheters may include fewer holes (e.g., two holes), while other variations of locking catheters may include more holes (e.g., six holes, eight holes, etc.). As the number of holes in a locking catheter increases, the likelihood of movement by a guide element that is threaded through the holes may decrease.
[0060] While one variation of a threading method is shown in FIGS. 5A-5D, other variations of threading methods may be used. For example, in some variations, a threading device, such as a threading rod, may be used to thread a guide element through a catheter. The guide element may be threaded around a groove in the threading rod, and/or may be threaded through one or more holes and/or lumens in the threading rod. The threading rod can provide support to the guide element, thereby making it easier to thread the guide element into the catheter. This, in turn, can reduce the total guide element-threading time. Threading devices are described, for example, in U.S. Pat. Appl. Serial No. 11/232,190, which is hereby incorporated by reference in its entirety. [0061] With reference now to FIGS. 8A and 41, after delivery catheter (424) has been advanced through tunnel catheter (410), delivery catheter (424) is advanced through opening (416) in distal portion (411) of tunnel catheter (410), and is used to deploy anchor (426).
[0062] FIG. 8B shows a cross-sectional view of tunnel catheter (410), straightened to show its dimensions. Opening (416), which is formed in a wall (450) of tunnel catheter (410), can be circular or non-circular. As shown in FIG. 8B, opening (416) has a dimension (D) which may be a length, a width, or a diameter of the opening. In some variations, such as when dimension (D) is a width of the opening, dimension (D) may be from about 0.08 inch to about 0.09 inch. In certain variations, such as when opening (416) is circular and dimension (D) is a diameter of the opening, dimension (D) may be from about 0.09 inch to about 0.15 inch. In some variations, such as when dimension (D) is a length of the opening, dimension (D) may be from about 0.15 inch to about 0.2 inch. Opening (416) may be formed in wall (450) using, any suitable technique, for example, with use of a laser.
[0063] As shown in FIG. 8B, tunnel catheter (410) has an inner diameter (IDl), an outer diameter (ODl), and a length (Ll). Length (Ll) may measure, for example, from about 46 inches to about 48 inches. In some variations, inner diameter (IDl) may be from about 0.085 inch to about 0.1 inch. Inner diameter (IDl) may be selected, for example, based on the dimensions of delivery catheter (424). As an example, if delivery catheter (424) has a relatively large outer diameter, then inner diameter (IDl) may also be relatively large, to provide for relatively rapid advancement of delivery catheter (424) through tunnel catheter (410). In some variations, outer diameter (ODl) may be from about 0.135 inch to about 0.15 inch. Outer diameter (ODl) may be selected, for example, based on the planned path for advancement of tunnel catheter (410) to the target tissue.
[0064] Tunnel catheter (410) can be formed of any of a number of different materials. Examples of suitable materials include polymers, such as polyether-block co- polyamide polymers, copolyester elastomers, thermoset polymers, polyolefins (e.g., polypropylene or polyethylene, including high-density polyethylene and low-density polyethylene), polytetrafluoroethylene, ethylene vinyl acetate, polyamides, polyimides, polyurethanes, polyvinyl chloride (PVC, fluoropolymers (e.g., fluorinated ethylene propylene, perfluoroalkoxy (PFA) polymer, polyvinylidenefluoride, etc.), polyetheretherketones (PEEKs), and silicones. Examples of polyamides that may be included in tunnel catheter (410) include Nylon 6 (e.g., Zytel® HTN high performance polyamides from DuPont™), Nylon 11 (e.g., Rilsan® B polyamides from Arkema Inc.), and Nylon 12 (e.g., Grilamid® polyamides from EMS-Grivory, Rilsan® A polyamides from Arkema Inc., and Vestamid® polyamides from Degussa Corp.). In some variations, tunnel catheter (410) may be formed of multiple polymers. For example, tunnel catheter (410) may be formed of a blend of different polymers, such as a blend of high-density polyethylene and low-density polyethylene. While wall (450) of tunnel catheter (410) is formed of a single layer, some variations of tunnel catheters may include walls having multiple layers (e.g., two layers, three layers). Furthermore, some variations of tunnel catheters may include at least two sections that are formed of different materials and/or that include different numbers of layers. Additionally, certain variations of tunnel catheters may include multiple (e.g., two, three) lumens. The lumens may, for example, be lined and/or reinforced (e.g., with braiding).
[0065] For example, FIGS. 14A and 14B shows a tunnel catheter (1400) having multiple lumens. As shown, tunnel catheter (1400) includes a body (1402) having a proximal section (1420), a transition section (1430), and a distal section (1440), and defining a primary lumen (1404) and a secondary lumen (1406). In some variations, primary lumen (1404) may be used to advance a delivery catheter to a target tissue, while secondary lumen (1406) may be used as an inflation lumen. For example, secondary lumen (1406) may be injected with a mix of 25% contrast agent and 75% heparinized saline to inflate a balloon carried by the tunnel catheter. Primary lumen (1404) is lined with a liner (1408) including a braided reinforcement (1410), and secondary lumen (1406) is similarly lined with a liner (1412) including a braided reinforcement (1414).
[0066] Body (1402) may be formed of one or more materials, such as one or more polymers. For example, in some variations, proximal section (1420) of body (1402) may be formed of a blend of high-density polyethylene (HDPE) and low-density polyethylene (LDPE), transition section (1430) of body (1402) may be formed of DuPont™ 20 low-density polyethylene (from DuPont™), and distal section (1440) may be formed of Elvax 450 ethylene vinyl acetate (from DuPont™). In such variations, proximal section (1420) may be about 28 inches long, transition section (1430) may be about eight inches long, and distal section (1440) may be about ten inches long. However, other lengths may be used for the proximal, transition, and distal sections.
[0067] Liner (1408) may be formed of high-density polyethylene or polytetrafluoroethylene (e.g., etched polytetrafluoroethylene), and liner (1412) may be formed of a flattened polyimide. Braided reinforcements (1410) and (1414) may be formed of the same material or different materials. An example of a material that may be suitable for one or both of the braided reinforcements is stainless steel, such as 304V stainless steel.
[0068] While FIGS. 8A and 8B show one variation of a tunnel catheter, it should be understood that other variations of tunnel catheters can be used for advancing a delivery catheter to a target site as well. For example, FIG. 9 shows a tunnel catheter (900), where a delivery catheter (902) is advanced out and through the distal end (904) of tunnel catheter (900).
[0069] FIG. 8C provides a cross-sectional view of delivery catheter (424), straightened to show its dimensions. As shown in FIG. 8C, delivery catheter (424) has an inner diameter (ID2), an outer diameter (OD2), and a length (L2). Length (L2) may be, for example, from about 120 centimeters to about 150 centimeters. In some variations, inner diameter (ID2) may be from about 0.045 inch to about 0.06 inch. Inner diameter (ID2) can be selected, for example, based on the sizes and/or types of anchors being deployed from the delivery catheter. In certain variations, outer diameter (OD2) may be from about 0.07 inch to about 0.095 inch.
[0070] Delivery catheter (424) can be formed of any of a number of different materials. Examples of suitable materials include polymers, such as the polymers described above with reference to tunnel catheter (410), metals (e.g., platinum, gold), metal alloys (e.g., nickel-titanium alloys such as Nitinol), and combinations of these materials. Delivery catheter (424) may be formed of some or all of the same materials as tunnel catheter (410), or may be formed of different materials from tunnel catheter (410). While delivery catheter (424) is shown as including a wall (425) that is formed of one layer, some variations of delivery catheters may include walls that are formed of multiple layers. Furthermore, delivery catheters may include at least two sections that are formed of different materials and/or that include different numbers of layers. [0071] While FIG. 8C shows one variation of a delivery catheter, any of a number of different types and configurations of delivery catheters can be used for implant delivery. A delivery catheter can have one lumen or multiple (e.g., two, three) lumens. In some variations, one section of a delivery catheter can have fewer lumens than another section of the delivery catheter. For example, a distal section of a delivery catheter may have one lumen, while a proximal section of the delivery catheter may have two or three lumens. The lumens in a delivery catheter may be, for example, guide element lumens and/or infusion lumens (e.g., for the infusion of one or more therapeutic agents into a target tissue). The lumens may be located in a variety of different regions of the delivery catheter. For example, a delivery catheter may include a generally tubular member and a lumen formed on a surface of the generally tubular member. The lumens in a delivery catheter may extend along the length of the delivery catheter, may be shorter than the delivery catheter, or may be a combination of the two. Furthermore, a lumen may be located only in a distal section of a delivery catheter, or only in a proximal section of a delivery catheter. Additionally, certain variations of delivery catheters, or other types of catheters, may include other structures through which a guide element can be threaded. As an example, some variations of delivery catheters may include slotted regions on their outer surfaces. The slotted regions may be used, for example, to thread the delivery catheters over a guide element.
[0072] FIGS. 12A-12D show different detailed views of a variation of a delivery catheter (1200) that can be used to deliver one or more anchors to a target site. As shown in FIG. 12A, delivery catheter (1200) has a distal region (1204) including a tip (1202), an anchor- holding region (1206) including a primary lumen (1208), an intermediate region (1210) including both primary lumen (1208) and a secondary lumen (1212), and a proximal region (1214) including primary lumen (1208). An anchor (1216) is disposed within primary lumen (1208), in the anchor-holding region (1206). While only one anchor is shown in the anchor- holding region, some variations of delivery catheters may include an anchor-holding region that is adapted to hold multiple anchors. Similarly, while the variation shown in FIGS. 12A-12D depict anchors adapted to be deployed from the distal end of the delivery catheter, it should be understood that the anchors may be deployed from any suitable region of the delivery catheter, as desirable. For example, if desirable, the anchor may be delivered out of a side port or hole on the delivery catheter. [0073] As shown in FIGS. 12A-12D, a tether (1218) is threaded into a slot (1219) of tip (1202) (shown in FIGS. 12C and 12D), and through an eyelet (1226) of anchor (1216). After extending through the eyelet, the tether exits primary lumen (1208), and extends along an exterior surface (1221) of delivery catheter (1200) for the remainder of the length of the anchor- holding region, as shown in FIG. 12C. The tether then enters secondary lumen (1212), and extends through the length of the secondary lumen, exiting the secondary lumen at an end of distal region (1214). An actuator (1220) is slidably disposed within primary lumen (1208), and can be used to deploy anchor (1216). The actuator is in the form of a pushable generally tubular member, although other forms of actuators may be used. For example, in some variations, a solid rod may be used as an actuator.
[0074] A retrieval suture (1224) is slidably disposed within actuator (1220), and extends past the distal end (1222) of the actuator. The retrieval suture loops through eyelet (1226) of anchor (1216), so that it is engaged with anchor (1216). In this way, anchors that have been misfired or misplaced may be retrieved proximally within delivery catheter (1200) for redeployment. The retrieval suture is also, of course, capable of being disengaged from anchor (1216) after appropriate placement of the anchor. In some variations, the retrieval suture may be disengaged from the anchor by pulling on the proximal end of the retrieval suture and withdrawing the retrieval suture from the anchor eyelet and the catheter. Retrieval suture (1224) may be formed of, for example, any of the tether materials described above. Furthermore, while a delivery catheter including a retrieval suture has been described, in some variations, a delivery catheter may not include a retrieval suture, or may include multiple retrieval sutures.
[0075] As it exits delivery catheter (424), anchor (426) self-expands and self- secures to tissue in the region of the mitral valve annulus (AN). Returning now to earlier figures, as shown in FIG. 41, anchor (426) self-secures to a different region of the mitral valve annulus from anchor (420).
[0076] FIG. 4J shows that while anchor (420) is fixedly attached to tether (422), anchor (426) is slidably coupled to tether (422). More specifically, anchor (420) includes an eyelet (438) that is fixedly attached to the tether at an attachment point (440), and anchor (426) includes an eyelet (436) through which the tether is threaded. The threading of the tether through eyelet (436) causes anchor (426) to be slidably engaged with the tether. Thus, if the tether is cinched, then the tether will slide through eyelet (436). Tether (422) can be threaded through multiple anchors in this manner.
[0077] As noted above, the method described with reference to FIGS. 4A-4I can be repeated as desired to deploy multiple (e.g., at least two, at least three) anchors that can self- secure to various regions of the mitral valve annulus (AN). As an example, in some variations, five different delivery catheters can be successively advanced over a single tether to deploy five anchors into different regions of the mitral valve annulus. As another example, in certain variations, eight anchors can be deployed into the mitral valve annulus, along an arc of about 240°. Again, the deployed anchors can be uniformly spaced apart, or can have varying amounts of space between them. After multiple anchors have been secured to the region of the mitral valve annulus, tether (422) can be cinched, thereby pulling the anchors closer together, and reducing the circumference of the mitral valve annulus.
[0078] Tether (422) can be terminated after the desired extent of reduction has been achieved (e.g., as determined by ultrasound and fluoroscopy). As an example, a clip can be attached to tether (422) proximal to the proximal-most anchor, to maintain the tension of tether (422) between the anchors. Tether (422) can then be cut proximal to the clip. As described in further detail below, in some variations, attachment and cutting can be achieved using a termination device, such as a termination catheter. For example, one or more cutting and/or locking catheters can be used to maintain the tension in a cinched guide element and to remove the unused portion of the guide element, after cinching has been completed. Termination devices are described, for example, in U.S. Pat. Appl. Serial Nos. 11/232,190 and 11/270,034, both of which are hereby incorporated by reference in their entirety.
[0079] Some methods of terminating tether (422) may include withdrawing tunnel catheter (410) from guide catheter (404) prior to advancing a termination catheter over tether (422) to the proximal-most anchor. The termination catheter may then be used for attachment and cutting of tether (422). Other methods may include first attaching a clip to tether (422) proximal to the proximal-most anchor to maintain the tension in tether (422), and then withdrawing tunnel catheter (410) from guide catheter (404). In certain variations, a method may include attaching tether (422) to the proximal-most secured anchor, and then cutting tether (422) proximal to the anchor to which tether (422) has been attached. Tether (422) can be attached to the proximal-most anchor using, for example, one or more adhesives, and/or one or more knotting, crimping, and/or tying techniques. While threading, cinching, and termination techniques have been described with respect to a tether, these techniques may be used with other guide elements as well.
[0080] A guide element can be threaded through a termination catheter in any of a number of different ways. For example, FIGS. 10A-10E show examples of different routings of tethers through locking catheters, and FIGS. 1 IA-11C show examples of different routings of tethers through cutting catheters.
[0081] Referring to FIG. 1OA, a locking catheter (1000) includes a tip (1002) and a shaft (1004). A tether (1006) is threaded through four openings in the tip, so that the locking catheter secures the tether, thereby maintaining the tension in the tether. While tether (1006) is threaded through four openings in tip (1002), guide elements can be threaded through different numbers of openings in a catheter tip. For example, FIG. 1OB shows a locking catheter (1014) including a tip (1015), and a tether (1016) that has been threaded through two openings in the tip of the locking catheter. In FIG. 1OC, a tether (1018) is threaded through three openings in a tip (1022) of a locking catheter (1024), and also is threaded into the shaft (1026) of the locking catheter. The tether eventually exits the shaft through an opening in the shaft. FIG. 1OD shows a tether (1030) that is threaded into the distal end (1031) of the tip (1034) of a locking catheter (1036), and that extends through the shaft (1040) of the locking catheter, exiting through an opening in the shaft. Guide elements can extend through varying lengths of a shaft of a delivery catheter. For example, while the tether in FIG. 1 OD extends through a relatively short length of the catheter shaft, FIG. 1 OE shows a tether that extends through a relatively long length of a catheter shaft. As shown in FIG. 1OE, a tether (1042) is threaded into an opening in a tip (1046) of a locking catheter (1048), and extends through almost the entire length of the shaft (1050) of the locking catheter. Tether (1042) exits the shaft through an opening in the proximal end (1051) of the shaft.
[0082] As noted above, guide elements may also be threaded through cutting catheters in different routing configurations. For example, FIG. 1 IA shows a cutting catheter (1100) including a tip portion (1102) and a shaft portion (1104). A tether (1106) is threaded through two openings in tip portion (1102). A cutting element (1108) is disposed within a lumen of shaft portion (1104), and can be used to cut the tether (e.g., after a cinching procedure has taken place). FIG. 1 IB shows a different routing configuration for a tether that is threaded through a cutting catheter. As shown in FIG. 1 IB, a cutting catheter (1110) includes a tip portion (1112) and a shaft portion (1114) containing a cutting element (1118). A tether (1116) is threaded into tip portion (1112) at its distal end (1119), and through three openings in the tip portion. Referring now to FIG. 11C, a cutting catheter (1120) includes a tip portion (1122) and a shaft portion (1124). A tether (1126) is threaded into the tip portion (1122) at its distal end (1127), and exits the tip portion through an opening that is proximal to distal end (1127). A cutting element (1128) is disposed within shaft portion (1124). Guide elements can be threaded through different numbers of holes in cutting catheters and/or through different locations in cutting catheters. All of the described threading variations are merely illustrative examples of suitable threading techniques.
[0083] Furthermore, while routing configurations for guide elements through locking catheters and cutting catheters have been shown, the routing configurations may be used in other types of catheters as well. Additionally, other routing configurations may be used to thread a guide element through a catheter. As an example, in some variations, a guide element may not be threaded through a tip of a catheter.
[0084] While the methods described herein have been described with respect to anchor deployment, the methods can be used to deploy any number and/or type of suitable implants. For example, an implant may include one or more anchors, may include a lead or electrode (e.g., a pacing electrode, a diagnostic electrode, an active electrode), or may include any other suitable implant. In some variations, an implant may include a fabric implant, or an annuloplasty ring, alone or in combination with one or more anchors. Additional examples of implants include implants that deliver therapy, such as drug-delivery implants, and implants that telemetry information, such as information about the conditions of the target site. For example, implants may be used to deliver growth factors and/or genetic regenerative factors. Implants are described, for example, in U.S. Pat. App. Serial Nos. 10/461,043, 10/656,797, 10/741,130, 10/776,682, 10/792,681, 10/901,019, 10/901,555, 10/901,554, 10/901,445, and 10/901,444, all of which are hereby incorporated by reference in their entirety.
[0085] While the methods and devices have been described in some detail here by way of illustration and example, such illustration and example is for purposes of clarity of understanding only. It will be readily apparent to those of ordinary skill in the art in light of the teachings herein that certain changes and modifications may be made thereto without departing from the spirit and scope of the appended claims.

Claims

CLAIMSWhat is claimed is:
1. A method comprising:
successively advancing a plurality of catheters over a guide element that is attached to a body tissue, wherein the guide element is not detached from the body tissue after the catheters have been advanced over the guide element.
2. The method of claim 1, wherein the body tissue is accessible minimally invasively.
3. The method of claim 1, further comprising deploying at least one implant from at least one of the plurality of catheters.
4. The method of claim 3, wherein the at least one implant is at least one anchor.
5. The method of claim 4, wherein the at least one anchor self- expands and self-secures into a region of the body tissue.
6. The method of claim 3, wherein the at least one implant is at least one electrode.
7. The method of claim 1, wherein the body tissue comprises heart tissue.
8. The method of claim 7, wherein the heart tissue comprises mitral valve tissue.
9. The method of claim 1, wherein at least one of the plurality of catheters is a drug delivery catheter.
10. The method of claim 1 , wherein at least one of the plurality of catheters is a locking catheter or a cutting catheter.
11. The method of claim 1 , wherein the tether comprises a suture.
12. The method of claim 1, wherein at least one of the plurality of catheters has a proximal section and a distal section, and defines a lumen that is located in the distal section and not in the proximal section.
13. The method of claim 12, wherein the lumen is configured to allow passage of a tether therethrough.
14. A method comprising:
successively advancing a plurality of catheters over a tether, wherein the tether is attached to a body tissue that is accessible minimally invasively.
15. The method of claim 14, further comprising deploying at least one implant from at least one of the plurality of catheters.
16. The method of claim 15, wherein the at least one implant is at least one anchor.
17. The method of claim 16, wherein the at least one anchor self- expands and self-secures into a region of the body tissue.
18. The method of claim 15, wherein the at least one implant is at least one electrode.
19. The method of claim 14, wherein the body tissue comprises heart tissue.
20. The method of claim 19, wherein the heart tissue comprises mitral valve tissue.
21. The method of claim 14, wherein at least one of the plurality of catheters is a drug delivery catheter.
22. The method of claim 14, wherein at least one of the plurality of catheters is a locking catheter or a cutting catheter.
23. The method of claim 14, wherein the tether comprises a suture.
24. The method of claim 14, wherein at least one of the plurality of catheters has a proximal section and a distal section, and defines a lumen that is located in the distal section and not in the proximal section.
25. The method of claim 24, wherein the lumen is configured to allow passage of a tether therethrough.
26. A method comprising:
advancing a first delivery catheter to a first region of a body tissue;
deploying a first anchor from the first delivery catheter, wherein the first anchor is attached to a guide element;
proximally withdrawing the first delivery catheter;
advancing a second delivery catheter over the guide element; and
deploying a second anchor from the second delivery catheter.
27. The method of claim 26, wherein the guide element comprises a tether.
28. The method of claim 27, wherein the tether comprises a suture.
29. The method of claim 28, wherein the suture comprises polyester impregnated with polytetrafluoroethylene.
30. The method of claim 26, wherein the second anchor is slidably coupled to the guide element.
31. The method of claim 30, wherein the second anchor comprises an eyelet, and the second anchor is slidably coupled to the guide element by engaging the guide element with a lasso and proximally withdrawing the lasso through the eyelet.
32. The method of claim 26, wherein the first and second anchors are deployed to different regions of the body tissue.
33. The method of claim 26, wherein the first and second anchors self- expand and self-secure into different regions of the body tissue.
34. The method of claim 26, wherein advancing the first delivery catheter to the first region of the body tissue comprises advancing the first delivery catheter through a tunnel catheter.
35. The method of claim 34, wherein the tunnel catheter comprises a generally tubular member having an opening.
36. The method of claim 35, wherein the opening is positioned on a side wall of the generally tubular member.
37. The method of claim 35, wherein the generally tubular member has a proximal end and a distal end, and the opening is located proximal to the distal end of the generally tubular member.
38. The method of claim 35, wherein advancing the first delivery catheter through the tunnel catheter comprises advancing a portion of the first delivery catheter through the opening in the wall of the generally tubular member.
39. The method of claim 34, further comprising positioning the tunnel catheter at a second region of the body tissue prior to advancing the second delivery catheter over the guide element.
40. The method of claim 34, wherein the tunnel catheter has a proximal portion and a distal portion, and the distal portion of the tunnel catheter is pre-shaped to include at least one curve.
41. The method of claim 26, wherein the method is used to deploy at least three anchors.
42. The method of claim 26, wherein the body tissue is heart tissue.
43. The method of claim 42, wherein the heart tissue comprises mitral valve tissue, where the mitral valve comprises an annulus.
44. The method of claim 43, further comprising cinching the guide element to reduce the circumference of the mitral valve annulus.
45. The method of claim 43, further comprising cinching the guide element to reduce mitral valve regurgitation.
46. The method of claim 43, further comprising cinching the guide element to effect a geometric change in at least one of the mitral valve annulus and tissue surrounding the mitral valve annulus.
47. The method of claim 43, further comprising cinching the guide element to enhance apposition of leaflets of the mitral valve.
48. The method of claim 26, wherein the second delivery catheter has a first lumen and a second lumen.
49. The method of claim 48, wherein the second anchor is releasably coupled to a suture that is disposed within the second lumen.
50. The method of claim 26, wherein the second delivery catheter has a proximal section and a distal section, and the second delivery catheter defines a lumen that is located in the distal section and not in the proximal section.
51. The method of claim 50, wherein the lumen is configured to allow passage of a tether therethrough.
52. A device for stabilizing a catheter with respect to a body tissue, wherein the catheter comprises an expandable member configured to engage against a first portion of tissue in order to stabilize the catheter with respect to a second portion of tissue.
53. The device of claim 52, wherein the expandable member is a low- pressure inflatable balloon and wherein the balloon is made of a compliant material.
54. The device of claim 53, wherein only a portion of the low-pressure balloon is configured to inflate.
55. The device of claim 52, wherein the expandable member is made from a shape memory material.
56. The device of claim 55, wherein the expandable member is made from a nickel titanium alloy.
57. A catheter for advancement along a tether comprising a first and a second lumen, wherein the first and second lumens are positioned adjacent to one another and wherein at least a portion of the first and second lumens is configured to allow the passage of the tether therethrough, and wherein the second lumen is accessible from the first lumen.
58. The catheter of claim 57, wherein the catheter has a proximal section and a distal section, and the second lumen that is located in the distal section and not in the proximal section.
59. The catheter of claim 57, wherein the catheter is a delivery catheter.
60. The catheter of claim 59, wherein the delivery catheter is configured to deliver at least one anchor and wherein the anchor is positioned in the first lumen.
61. The catheter of claim 57, wherein the catheter is a cutting catheter.
62. The catheter of claim 57, wherein the catheter is a termination catheter.
PCT/US2007/022122 2006-10-18 2007-10-16 Methods and devices for catheter advancement and delivery of substances therethrough WO2008048626A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP07852809A EP2081627A4 (en) 2006-10-18 2007-10-16 Methods and devices for catheter advancement and delivery of substances therethrough
JP2009533354A JP2010506658A (en) 2006-10-18 2007-10-16 Method and apparatus for catheter advancement and delivery of substances through the catheter
AU2007313197A AU2007313197B2 (en) 2006-10-18 2007-10-16 Methods and devices for catheter advancement and delivery of substances therethrough
EP18167829.3A EP3420921B1 (en) 2006-10-18 2007-10-16 Devices for catheter advancement and delivery of anchors
CA2666862A CA2666862C (en) 2006-10-18 2007-10-16 Methods and devices for catheter advancement and delivery of substances therethrough
IL198206A IL198206A0 (en) 2006-10-18 2009-04-19 Methods and devices for catheter advancement and delivery of substances therethrough

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/583,627 US8388680B2 (en) 2006-10-18 2006-10-18 Methods and devices for catheter advancement and delivery of substances therethrough
US11/583,627 2006-10-18

Publications (2)

Publication Number Publication Date
WO2008048626A2 true WO2008048626A2 (en) 2008-04-24
WO2008048626A3 WO2008048626A3 (en) 2008-06-26

Family

ID=39314652

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/022122 WO2008048626A2 (en) 2006-10-18 2007-10-16 Methods and devices for catheter advancement and delivery of substances therethrough

Country Status (7)

Country Link
US (1) US8388680B2 (en)
EP (4) EP3420921B1 (en)
JP (1) JP2010506658A (en)
AU (4) AU2007313197B2 (en)
CA (1) CA2666862C (en)
IL (1) IL198206A0 (en)
WO (1) WO2008048626A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009052427A1 (en) * 2007-10-19 2009-04-23 Guided Delivery Systems Inc. Systems and methods for cardiac remodeling
EP2412397A1 (en) * 2006-10-18 2012-02-01 Guided Delivery Systems, Inc. Catheter for implant deployment
CN103654890A (en) * 2012-09-20 2014-03-26 德普伊米特克有限责任公司 Suture leader
FR2998167A1 (en) * 2013-03-20 2014-05-23 Marco Vola DEVICE FOR PERFORMING AN ANNULOPLASTY BY THE TRANSAPICAL PATH OF THE MITRAL VALVE
US9173646B2 (en) 2009-01-20 2015-11-03 Guided Delivery Systems Inc. Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods
US10058321B2 (en) 2015-03-05 2018-08-28 Ancora Heart, Inc. Devices and methods of visualizing and determining depth of penetration in cardiac tissue
US10363392B2 (en) 2008-05-07 2019-07-30 Ancora Heart, Inc. Deflectable guide
WO2019164516A1 (en) * 2018-02-22 2019-08-29 Edwards Lifesciences Corporation Heart valve docking devices and systems
US11672524B2 (en) 2019-07-15 2023-06-13 Ancora Heart, Inc. Devices and methods for tether cutting
US11690708B2 (en) 2016-08-26 2023-07-04 Edwards Lifesciences Corporation Heart valve docking system

Families Citing this family (225)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US9949829B2 (en) 2002-06-13 2018-04-24 Ancora Heart, Inc. Delivery devices and methods for heart valve repair
EP1530441B1 (en) 2002-06-13 2017-08-02 Ancora Heart, Inc. Devices and methods for heart valve repair
US8641727B2 (en) 2002-06-13 2014-02-04 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
DE202004021944U1 (en) 2003-09-12 2013-07-16 Vessix Vascular, Inc. Selectable eccentric remodeling and / or ablation of atherosclerotic material
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US9974607B2 (en) 2006-10-18 2018-05-22 Vessix Vascular, Inc. Inducing desirable temperature effects on body tissue
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
WO2006063199A2 (en) 2004-12-09 2006-06-15 The Foundry, Inc. Aortic valve repair
US8608797B2 (en) 2005-03-17 2013-12-17 Valtech Cardio Ltd. Mitral valve treatment techniques
US20090082619A1 (en) * 2005-06-09 2009-03-26 De Marchena Eduardo Method of treating cardiomyopathy
US8951285B2 (en) 2005-07-05 2015-02-10 Mitralign, Inc. Tissue anchor, anchoring system and methods of using the same
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
EP2455036B1 (en) 2006-10-18 2015-07-15 Vessix Vascular, Inc. Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
CA2666663C (en) 2006-10-18 2016-02-09 Minnow Medical, Inc. System for inducing desirable temperature effects on body tissue
US11259924B2 (en) 2006-12-05 2022-03-01 Valtech Cardio Ltd. Implantation of repair devices in the heart
US9974653B2 (en) 2006-12-05 2018-05-22 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
CN101917916B (en) * 2007-07-24 2014-06-25 创新医疗卫生器材有限责任公司 Catheter tunneler
DE102007043830A1 (en) 2007-09-13 2009-04-02 Lozonschi, Lucian, Madison Heart valve stent
CA2702446C (en) 2007-10-19 2019-03-05 Guided Delivery Systems, Inc. Devices and methods for termination
CA2713934C (en) 2008-02-06 2015-10-20 Guided Delivery Systems, Inc. Multi-window guide tunnel
US8382829B1 (en) 2008-03-10 2013-02-26 Mitralign, Inc. Method to reduce mitral regurgitation by cinching the commissure of the mitral valve
EP2296744B1 (en) 2008-06-16 2019-07-31 Valtech Cardio, Ltd. Annuloplasty devices
KR20110084912A (en) 2008-10-10 2011-07-26 가이디드 딜리버리 시스템즈 인코퍼레이티드 Tether tensioning devices and related methods
BRPI0920406A2 (en) 2008-10-10 2019-09-24 Guided Delivery Systems Inc termination devices and related methods.
DE102008043452A1 (en) * 2008-11-04 2010-05-06 Biotronik Crm Patent Ag Device for introducing medical implants
WO2010056745A1 (en) 2008-11-17 2010-05-20 Minnow Medical, Inc. Selective accumulation of energy with or without knowledge of tissue topography
US8147542B2 (en) 2008-12-22 2012-04-03 Valtech Cardio, Ltd. Adjustable repair chords and spool mechanism therefor
EP2379008B1 (en) 2008-12-22 2021-02-17 Valtech Cardio, Ltd. Adjustable annuloplasty devices
US8715342B2 (en) 2009-05-07 2014-05-06 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US9011530B2 (en) 2008-12-22 2015-04-21 Valtech Cardio, Ltd. Partially-adjustable annuloplasty structure
US8911494B2 (en) 2009-05-04 2014-12-16 Valtech Cardio, Ltd. Deployment techniques for annuloplasty ring
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US8241351B2 (en) 2008-12-22 2012-08-14 Valtech Cardio, Ltd. Adjustable partial annuloplasty ring and mechanism therefor
EP2389218A4 (en) 2009-01-20 2012-06-13 Guided Delivery Systems Inc Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods
EP2381852A4 (en) * 2009-01-21 2014-06-11 Tendyne Medical Inc Apical papillary muscle attachment for left ventricular reduction
US8353956B2 (en) 2009-02-17 2013-01-15 Valtech Cardio, Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
US20110015476A1 (en) * 2009-03-04 2011-01-20 Jeff Franco Devices and Methods for Treating Cardiomyopathy
US9968452B2 (en) 2009-05-04 2018-05-15 Valtech Cardio, Ltd. Annuloplasty ring delivery cathethers
US10098737B2 (en) 2009-10-29 2018-10-16 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US9180007B2 (en) 2009-10-29 2015-11-10 Valtech Cardio, Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
US9011520B2 (en) 2009-10-29 2015-04-21 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US20110106230A1 (en) * 2009-11-04 2011-05-05 Erhard Flach Placement device for inserting medical implants such as electrode lines
WO2011067770A1 (en) 2009-12-02 2011-06-09 Valtech Cardio, Ltd. Delivery tool for implantation of spool assembly coupled to a helical anchor
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
EP2509538B1 (en) 2009-12-08 2017-09-20 Avalon Medical Ltd. Device and system for transcatheter mitral valve replacement
US20110196187A1 (en) * 2010-02-11 2011-08-11 Abbott Cardiovascular Systems Inc. Magnetically sensitive drug carriers and delivery devices
WO2011109813A2 (en) * 2010-03-05 2011-09-09 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
KR20130108067A (en) 2010-04-09 2013-10-02 베식스 바스큘라 인코포레이티드 Power generating and control apparatus for the treatment of tissue
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9861350B2 (en) 2010-09-03 2018-01-09 Ancora Heart, Inc. Devices and methods for anchoring tissue
US10321998B2 (en) 2010-09-23 2019-06-18 Transmural Systems Llc Methods and systems for delivering prostheses using rail techniques
TWI556849B (en) 2010-10-21 2016-11-11 美敦力阿福盧森堡公司 Catheter apparatus for renal neuromodulation
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US9220561B2 (en) 2011-01-19 2015-12-29 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
WO2012161875A1 (en) 2011-04-08 2012-11-29 Tyco Healthcare Group Lp Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
WO2012148969A2 (en) 2011-04-25 2012-11-01 Brian Kelly Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9918840B2 (en) 2011-06-23 2018-03-20 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US10792152B2 (en) 2011-06-23 2020-10-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
WO2013013156A2 (en) 2011-07-20 2013-01-24 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
JP6106669B2 (en) 2011-07-22 2017-04-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. A neuromodulation system having a neuromodulation element that can be placed in a helical guide
CA3040390C (en) 2011-08-11 2022-03-15 Tendyne Holdings, Inc. Improvements for prosthetic valves and related inventions
US9549817B2 (en) 2011-09-22 2017-01-24 Transmural Systems Llc Devices, systems and methods for repairing lumenal systems
EP2765942B1 (en) 2011-10-10 2016-02-24 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
EP2765940B1 (en) 2011-10-11 2015-08-26 Boston Scientific Scimed, Inc. Off-wall electrode device for nerve modulation
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
EP2768563B1 (en) 2011-10-18 2016-11-09 Boston Scientific Scimed, Inc. Deflectable medical devices
EP2768568B1 (en) 2011-10-18 2020-05-06 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
US8858623B2 (en) 2011-11-04 2014-10-14 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
EP3656434B1 (en) 2011-11-08 2021-10-20 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
WO2013070724A1 (en) 2011-11-08 2013-05-16 Boston Scientific Scimed, Inc. Ostial renal nerve ablation
EP2779929A1 (en) 2011-11-15 2014-09-24 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
WO2013096920A1 (en) 2011-12-23 2013-06-27 Vessix Vascular, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
WO2013101452A1 (en) 2011-12-28 2013-07-04 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US10660703B2 (en) 2012-05-08 2020-05-26 Boston Scientific Scimed, Inc. Renal nerve modulation devices
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
WO2014022124A1 (en) 2012-07-28 2014-02-06 Tendyne Holdings, Inc. Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly
WO2014021905A1 (en) 2012-07-30 2014-02-06 Tendyne Holdings, Inc. Improved delivery systems and methods for transcatheter prosthetic valves
US10321946B2 (en) 2012-08-24 2019-06-18 Boston Scientific Scimed, Inc. Renal nerve modulation devices with weeping RF ablation balloons
CN104780859B (en) 2012-09-17 2017-07-25 波士顿科学西美德公司 Self-positioning electrode system and method for renal regulation
US10549127B2 (en) 2012-09-21 2020-02-04 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
US10398464B2 (en) 2012-09-21 2019-09-03 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
WO2014052818A1 (en) 2012-09-29 2014-04-03 Mitralign, Inc. Plication lock delivery system and method of use thereof
CN104869930B (en) 2012-10-10 2020-12-25 波士顿科学国际有限公司 Renal neuromodulation apparatus and methods
US9044575B2 (en) 2012-10-22 2015-06-02 Medtronic Adrian Luxembourg S.a.r.l. Catheters with enhanced flexibility and associated devices, systems, and methods
US10376266B2 (en) 2012-10-23 2019-08-13 Valtech Cardio, Ltd. Percutaneous tissue anchor techniques
WO2014064694A2 (en) 2012-10-23 2014-05-01 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US9730793B2 (en) 2012-12-06 2017-08-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
EP2948103B1 (en) 2013-01-24 2022-12-07 Cardiovalve Ltd Ventricularly-anchored prosthetic valves
EP2961351B1 (en) 2013-02-26 2018-11-28 Mitralign, Inc. Devices for percutaneous tricuspid valve repair
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
WO2014163987A1 (en) 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US10449333B2 (en) 2013-03-14 2019-10-22 Valtech Cardio, Ltd. Guidewire feeder
EP2967734B1 (en) 2013-03-15 2019-05-15 Boston Scientific Scimed, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US9724195B2 (en) 2013-03-15 2017-08-08 Mitralign, Inc. Translation catheters and systems
WO2014149690A2 (en) 2013-03-15 2014-09-25 Boston Scientific Scimed, Inc. Medical devices and methods for treatment of hypertension that utilize impedance compensation
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
US9486306B2 (en) 2013-04-02 2016-11-08 Tendyne Holdings, Inc. Inflatable annular sealing device for prosthetic mitral valve
US11224510B2 (en) 2013-04-02 2022-01-18 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10463489B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10478293B2 (en) 2013-04-04 2019-11-19 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
WO2014189794A1 (en) 2013-05-18 2014-11-27 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices, systems, and methods
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
CN105473092B (en) 2013-06-21 2019-05-17 波士顿科学国际有限公司 The medical instrument for renal nerve ablation with rotatable shaft
JP2016523147A (en) 2013-06-21 2016-08-08 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Renal denervation balloon catheter with a riding-type electrode support
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
CN105658178B (en) 2013-06-25 2018-05-08 坦迪尼控股股份有限公司 Feature is complied with thrombus management and structure for prosthetic heart valve
AU2014284558B2 (en) 2013-07-01 2017-08-17 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
WO2015006573A1 (en) 2013-07-11 2015-01-15 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
US10660698B2 (en) 2013-07-11 2020-05-26 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
CN105682594B (en) 2013-07-19 2018-06-22 波士顿科学国际有限公司 Helical bipolar electrodes renal denervation dominates air bag
EP3024406B1 (en) 2013-07-22 2019-06-19 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
JP6122217B2 (en) 2013-07-22 2017-04-26 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Renal nerve ablation medical device
CA2919379C (en) 2013-08-01 2021-03-30 Tendyne Holdings, Inc. Epicardial anchor devices and methods
US10722300B2 (en) 2013-08-22 2020-07-28 Boston Scientific Scimed, Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
US10070857B2 (en) 2013-08-31 2018-09-11 Mitralign, Inc. Devices and methods for locating and implanting tissue anchors at mitral valve commissure
EP3041425B1 (en) 2013-09-04 2022-04-13 Boston Scientific Scimed, Inc. Radio frequency (rf) balloon catheter having flushing and cooling capability
WO2015038947A1 (en) 2013-09-13 2015-03-19 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
CN105592778B (en) 2013-10-14 2019-07-23 波士顿科学医学有限公司 High-resolution cardiac mapping electrod-array conduit
CN105636537B (en) 2013-10-15 2018-08-17 波士顿科学国际有限公司 Medical instrument sacculus
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
WO2015058039A1 (en) 2013-10-17 2015-04-23 Robert Vidlund Apparatus and methods for alignment and deployment of intracardiac devices
WO2015057961A1 (en) 2013-10-18 2015-04-23 Boston Scientific Scimed, Inc. Balloon catheters with flexible conducting wires and related methods of use and manufacture
US10299793B2 (en) 2013-10-23 2019-05-28 Valtech Cardio, Ltd. Anchor magazine
WO2015061457A1 (en) 2013-10-25 2015-04-30 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
JP6554094B2 (en) 2013-10-28 2019-07-31 テンダイン ホールディングス,インコーポレイテッド Prosthetic heart valve and system and method for delivering an artificial heart valve
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
WO2015075558A2 (en) * 2013-11-25 2015-05-28 Body Vision Medical Ltd. Surgical devices and methods of use thereof
US9610162B2 (en) 2013-12-26 2017-04-04 Valtech Cardio, Ltd. Implantation of flexible implant
JP6382989B2 (en) 2014-01-06 2018-08-29 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device with tear resistant flexible circuit assembly
EP4059563B1 (en) 2014-01-27 2023-09-27 Medtronic Ireland Manufacturing Unlimited Company Neuromodulation catheters having jacketed neuromodulation elements and related devices
CN106572881B (en) 2014-02-04 2019-07-26 波士顿科学国际有限公司 Substitution of the heat sensor on bipolar electrode is placed
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
WO2015120122A2 (en) 2014-02-05 2015-08-13 Robert Vidlund Apparatus and methods for transfemoral delivery of prosthetic mitral valve
US9986993B2 (en) 2014-02-11 2018-06-05 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
CA2937566C (en) 2014-03-10 2023-09-05 Tendyne Holdings, Inc. Devices and methods for positioning and monitoring tether load for prosthetic mitral valve
US20170014115A1 (en) 2014-03-27 2017-01-19 Transmural Systems Llc Devices and methods for closure of transvascular or transcameral access ports
CN106232043B (en) 2014-04-24 2019-07-23 美敦力阿迪安卢森堡有限公司 Nerve modulation conduit and relevant system and method with braiding axle
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US10194897B2 (en) * 2014-07-18 2019-02-05 Ethicon, Inc. Mechanical retraction via tethering for lung volume reduction
US10195030B2 (en) 2014-10-14 2019-02-05 Valtech Cardio, Ltd. Leaflet-restraining techniques
US9682216B2 (en) 2014-12-05 2017-06-20 Anchor Endovascular, Inc. Anchor device for use with catheters
JP6826035B2 (en) 2015-01-07 2021-02-03 テンダイン ホールディングス,インコーポレイテッド Artificial mitral valve, and devices and methods for its delivery
EP3253333B1 (en) 2015-02-05 2024-04-03 Cardiovalve Ltd Prosthetic valve with axially-sliding frames
AU2016215197B2 (en) 2015-02-05 2020-01-02 Tendyne Holdings Inc. Expandable epicardial pads and devices and methods for their delivery
US20160256269A1 (en) 2015-03-05 2016-09-08 Mitralign, Inc. Devices for treating paravalvular leakage and methods use thereof
EP4070763A1 (en) 2015-04-16 2022-10-12 Tendyne Holdings, Inc. Apparatus for retrieval of transcathter prosthetic valves
CN114515173A (en) 2015-04-30 2022-05-20 瓦尔泰克卡迪欧有限公司 Valvuloplasty techniques
EP4074285A1 (en) 2015-05-12 2022-10-19 Ancora Heart, Inc. Device for releasing catheters from cardiac structures
WO2017049003A1 (en) 2015-09-15 2017-03-23 Nasser Rafiee Devices and methods for effectuating percutaneous glenn and fontan procedures
US10327894B2 (en) 2015-09-18 2019-06-25 Tendyne Holdings, Inc. Methods for delivery of prosthetic mitral valves
AU2016362474B2 (en) 2015-12-03 2021-04-22 Tendyne Holdings, Inc. Frame features for prosthetic mitral valves
AU2016380259B2 (en) 2015-12-28 2020-10-22 Tendyne Holdings, Inc. Atrial pocket closures for prosthetic heart valves
US10751182B2 (en) 2015-12-30 2020-08-25 Edwards Lifesciences Corporation System and method for reshaping right heart
WO2017117370A2 (en) 2015-12-30 2017-07-06 Mitralign, Inc. System and method for reducing tricuspid regurgitation
DE202017007326U1 (en) 2016-01-29 2020-10-20 Neovasc Tiara Inc. Valve prosthesis to prevent flow obstruction
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US10470877B2 (en) 2016-05-03 2019-11-12 Tendyne Holdings, Inc. Apparatus and methods for anterior valve leaflet management
US10702274B2 (en) 2016-05-26 2020-07-07 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
EP3468480B1 (en) 2016-06-13 2023-01-11 Tendyne Holdings, Inc. Sequential delivery of two-part prosthetic mitral valve
EP3478224B1 (en) 2016-06-30 2022-11-02 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus for delivery of same
GB201611910D0 (en) 2016-07-08 2016-08-24 Valtech Cardio Ltd Adjustable annuloplasty device with alternating peaks and troughs
EP3484411A1 (en) 2016-07-12 2019-05-22 Tendyne Holdings, Inc. Apparatus and methods for trans-septal retrieval of prosthetic heart valves
WO2018029680A1 (en) 2016-08-10 2018-02-15 Mitraltech Ltd. Prosthetic valve with concentric frames
CN106388880B (en) * 2016-10-21 2019-06-14 武汉唯柯医疗科技有限公司 A kind of annulus of mitral valve contracting intervention device
CN109996581B (en) 2016-11-21 2021-10-15 内奥瓦斯克迪亚拉公司 Methods and systems for rapid retrieval of transcatheter heart valve delivery systems
US11045627B2 (en) 2017-04-18 2021-06-29 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
US10595998B2 (en) * 2017-06-19 2020-03-24 Medtentia International Ltd Oy Method of repairing a defective heart valve
WO2019014473A1 (en) 2017-07-13 2019-01-17 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
USD890333S1 (en) 2017-08-21 2020-07-14 Edwards Lifesciences Corporation Heart valve docking coil
CN111263622A (en) 2017-08-25 2020-06-09 内奥瓦斯克迪亚拉公司 Sequentially deployed transcatheter mitral valve prosthesis
WO2019046099A1 (en) 2017-08-28 2019-03-07 Tendyne Holdings, Inc. Prosthetic heart valves with tether coupling features
US10835221B2 (en) 2017-11-02 2020-11-17 Valtech Cardio, Ltd. Implant-cinching devices and systems
US11135062B2 (en) 2017-11-20 2021-10-05 Valtech Cardio Ltd. Cinching of dilated heart muscle
US11116561B2 (en) 2018-01-24 2021-09-14 Medtronic Ardian Luxembourg S.A.R.L. Devices, agents, and associated methods for selective modulation of renal nerves
CN111655200B (en) 2018-01-24 2023-07-14 爱德华兹生命科学创新(以色列)有限公司 Contraction of annuloplasty structures
WO2019145941A1 (en) 2018-01-26 2019-08-01 Valtech Cardio, Ltd. Techniques for facilitating heart valve tethering and chord replacement
US11285003B2 (en) 2018-03-20 2022-03-29 Medtronic Vascular, Inc. Prolapse prevention device and methods of use thereof
US11026791B2 (en) 2018-03-20 2021-06-08 Medtronic Vascular, Inc. Flexible canopy valve repair systems and methods of use
CA3106104A1 (en) 2018-07-12 2020-01-16 Valtech Cardio, Ltd. Annuloplasty systems and locking tools therefor
EP3876870B1 (en) 2018-11-08 2023-12-20 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
JP7438236B2 (en) 2019-04-01 2024-02-26 ニオバスク ティアラ インコーポレイテッド Controllably deployable prosthetic valve
CA3136334A1 (en) 2019-04-10 2020-10-15 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
AU2020279750B2 (en) 2019-05-20 2023-07-13 Neovasc Tiara Inc. Introducer with hemostasis mechanism
AU2020295566B2 (en) 2019-06-20 2023-07-20 Neovasc Tiara Inc. Low profile prosthetic mitral valve
CN114786621A (en) 2019-10-29 2022-07-22 爱德华兹生命科学创新(以色列)有限公司 Annuloplasty and tissue anchoring techniques
US11648110B2 (en) 2019-12-05 2023-05-16 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
US11678980B2 (en) 2020-08-19 2023-06-20 Tendyne Holdings, Inc. Fully-transseptal apical pad with pulley for tensioning

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020133092A1 (en) 2001-03-16 2002-09-19 Microvena Corporation Wire convertible from over-the-wire length to rapid exchange length
US20040186486A1 (en) 1999-09-20 2004-09-23 Ev3 Sunnyvale, Inc. Method of closing an opening in a wall of the heart

Family Cites Families (190)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL143127B (en) 1969-02-04 1974-09-16 Rhone Poulenc Sa REINFORCEMENT DEVICE FOR A DEFECTIVE HEART VALVE.
US3773034A (en) 1971-11-24 1973-11-20 Itt Research Institute Steerable catheter
US3976079A (en) 1974-08-01 1976-08-24 Samuels Peter B Securing devices for sutures
US3961419A (en) 1975-06-30 1976-06-08 Boris Schwartz Method of cutting and removing sutures
US4053979A (en) 1975-12-23 1977-10-18 International Paper Company Suture cutter
US4034473A (en) 1975-12-23 1977-07-12 International Paper Company Suture cutter
US4069825A (en) 1976-01-28 1978-01-24 Taichiro Akiyama Surgical thread and cutting apparatus for the same
US4042979A (en) 1976-07-12 1977-08-23 Angell William W Valvuloplasty ring and prosthetic method
US4273127A (en) 1978-10-12 1981-06-16 Research Corporation Method for cutting and coagulating tissue
ES244903Y (en) 1979-07-31 1980-12-01 ADJUSTABLE CANCELLATION OF PROSTHESIS FOR CARDIAC SURGERY
US4384406A (en) 1981-03-05 1983-05-24 Cordis Corporation Combination suture cutter and remover
US4445509A (en) 1982-02-04 1984-05-01 Auth David C Method and apparatus for removal of enclosed abnormal deposits
US4726371A (en) 1982-02-09 1988-02-23 Gibbens Everett N Surgical cutting instrument
CA1176130A (en) 1982-03-31 1984-10-16 Mary K. Lee Suture cutter and extractor
US4489446A (en) 1982-07-14 1984-12-25 Reed Charles C Heart valve prosthesis
US4758221A (en) 1986-02-18 1988-07-19 St. Louis University Catheter with a tip manipulation feature
US5314407A (en) 1986-11-14 1994-05-24 Heart Technology, Inc. Clinically practical rotational angioplasty system
GB8628090D0 (en) 1986-11-25 1986-12-31 Ahmad R Clipon surgical suture cutter
US5437680A (en) 1987-05-14 1995-08-01 Yoon; Inbae Suturing method, apparatus and system for use in endoscopic procedures
US4850354A (en) 1987-08-13 1989-07-25 Baxter Travenol Laboratories, Inc. Surgical cutting instrument
US4845851A (en) 1987-12-09 1989-07-11 Milliken Research Corporation Synthetic suture cutting device
US5053047A (en) 1989-05-16 1991-10-01 Inbae Yoon Suture devices particularly useful in endoscopic surgery and methods of suturing
US4969893A (en) 1989-06-16 1990-11-13 Swor G Michael Disposable suture cutter and needle holder
US5221255A (en) 1990-01-10 1993-06-22 Mahurkar Sakharam D Reinforced multiple lumen catheter
US5084058A (en) 1990-04-25 1992-01-28 Mitek Surgical Products, Inc. Suture rundown tool and cutter system
US5133723A (en) 1990-04-25 1992-07-28 Mitek Surgical Products, Inc. Suture rundown tool and cutter system
US5064431A (en) 1991-01-16 1991-11-12 St. Jude Medical Incorporated Annuloplasty ring
US5571215A (en) 1993-02-22 1996-11-05 Heartport, Inc. Devices and methods for intracardiac procedures
US5735290A (en) 1993-02-22 1998-04-07 Heartport, Inc. Methods and systems for performing thoracoscopic coronary bypass and other procedures
US5195990A (en) 1991-09-11 1993-03-23 Novoste Corporation Coronary catheter
US6183469B1 (en) 1997-08-27 2001-02-06 Arthrocare Corporation Electrosurgical systems and methods for the removal of pacemaker leads
US5417700A (en) 1992-03-30 1995-05-23 Thomas D. Egan Automatic suturing and ligating device
AU5356894A (en) 1992-10-09 1994-05-09 Li Medical Technologies, Inc. Suture throw rundown tool
US5383905A (en) 1992-10-09 1995-01-24 United States Surgical Corporation Suture loop locking device
US5324298A (en) 1992-11-03 1994-06-28 Edward H. Phillips Endoscopic knot pushing instrument
US5718725A (en) 1992-12-03 1998-02-17 Heartport, Inc. Devices and methods for intracardiac procedures
US5368564A (en) 1992-12-23 1994-11-29 Angeion Corporation Steerable catheter
WO1994015535A1 (en) 1993-01-07 1994-07-21 Hayhurst, John, O. Clip for suture
US5346500A (en) 1993-02-16 1994-09-13 Sood Suchart Suture cutting scissor apparatus
US6125852A (en) 1993-02-22 2000-10-03 Heartport, Inc. Minimally-invasive devices and methods for treatment of congestive heart failure
US5527323A (en) 1993-06-02 1996-06-18 General Surgical Innovations, Inc. Surgical instrument for tying a knot in a length of suture at a remote location
US6203531B1 (en) 1993-11-03 2001-03-20 Daig Corporation Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach
US5640955A (en) 1995-02-14 1997-06-24 Daig Corporation Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach
US5358479A (en) 1993-12-06 1994-10-25 Electro-Catheter Corporation Multiform twistable tip deflectable catheter
US5423837A (en) 1993-12-14 1995-06-13 Advanced Surgical, Inc. Surgical knot pusher
US5536270A (en) 1994-02-24 1996-07-16 Pioneer Laboratories, Inc. Cable system for bone securance
CA2141911C (en) 1994-02-24 2002-04-23 Jude S. Sauer Surgical crimping device and method of use
US5545168A (en) 1994-03-11 1996-08-13 Burke; Dennis W. Apparatus for both tensioning and crimping a surgical wire
US5364407A (en) 1994-03-21 1994-11-15 Poll Wayne L Laparoscopic suturing system
GB9405791D0 (en) 1994-03-23 1994-05-11 Univ London Device for use in cutting threads
US5630824A (en) 1994-06-01 1997-05-20 Innovasive Devices, Inc. Suture attachment device
US5452513A (en) 1994-06-29 1995-09-26 Eric Hulsman Suture cutter
AU3683995A (en) 1994-09-28 1996-04-19 Innovasive Devices, Inc. Suture tensioning device
US6540755B2 (en) 1995-02-14 2003-04-01 Daig Corporation Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US5626614A (en) 1995-12-22 1997-05-06 Applied Medical Resources Corporation T-anchor suturing device and method for using same
US5817107A (en) 1995-12-28 1998-10-06 Schaller; Guenter Grasping instrument with a guided-on, attachable modified knot pusher
US5810853A (en) 1996-01-16 1998-09-22 Yoon; Inbae Knotting element for use in suturing anatomical tissue and methods therefor
US5735877A (en) 1996-02-28 1998-04-07 Pagedas; Anthony C. Self locking suture lock
US5752964A (en) 1996-04-16 1998-05-19 Mericle; Robert W. Surgical knot pusher with flattened spatulated tip
US5919208A (en) 1996-06-27 1999-07-06 Valenti; Gabriele Suture block for surgical sutures
US5904147A (en) 1996-08-16 1999-05-18 University Of Massachusetts Intravascular catheter and method of controlling hemorrhage during minimally invasive surgery
US5810848A (en) 1996-08-21 1998-09-22 Hayhurst; John O. Suturing system
US5860993A (en) 1996-09-25 1999-01-19 Medworks Corp. Suture cutter
US6050936A (en) 1997-01-02 2000-04-18 Myocor, Inc. Heart wall tension reduction apparatus
US5961440A (en) 1997-01-02 1999-10-05 Myocor, Inc. Heart wall tension reduction apparatus and method
US6077214A (en) 1998-07-29 2000-06-20 Myocor, Inc. Stress reduction apparatus and method
US6406420B1 (en) 1997-01-02 2002-06-18 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US5879371A (en) 1997-01-09 1999-03-09 Elective Vascular Interventions, Inc. Ferruled loop surgical fasteners, instruments, and methods for minimally invasive vascular and endoscopic surgery
DE19704580C2 (en) 1997-02-07 1999-04-01 Storz Karl Gmbh & Co Surgical thread cutter
US5904657A (en) * 1997-02-26 1999-05-18 Unsworth; John D. System for guiding devices in body lumens
US5904692A (en) * 1997-04-14 1999-05-18 Mitek Surgical Products, Inc. Needle assembly and method for passing suture
US6015428A (en) 1997-06-03 2000-01-18 Anthony C. Pagedas Integrally formed suture and suture lock
US5902321A (en) 1997-07-25 1999-05-11 Innovasive Devices, Inc. Device and method for delivering a connector for surgically joining and securing flexible tissue repair members
US5916147A (en) 1997-09-22 1999-06-29 Boury; Harb N. Selectively manipulable catheter
US6056743A (en) 1997-11-04 2000-05-02 Scimed Life Systems, Inc. Percutaneous myocardial revascularization device and method
US20020087148A1 (en) 1998-02-24 2002-07-04 Brock David L. Flexible instrument
US6260552B1 (en) 1998-07-29 2001-07-17 Myocor, Inc. Transventricular implant tools and devices
US6648903B1 (en) 1998-09-08 2003-11-18 Pierson, Iii Raymond H. Medical tensioning system
US6261304B1 (en) * 1998-09-10 2001-07-17 Percardia, Inc. Delivery methods for left ventricular conduit
EP1112102A1 (en) 1998-09-10 2001-07-04 Percardia, Inc. Tunneling catheter system for artificial ventricular wall conduit
US6066160A (en) 1998-11-23 2000-05-23 Quickie Llc Passive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing
US6258118B1 (en) 1998-11-25 2001-07-10 Israel Aircraft Industries Ltd. Removable support device
DE69931018T2 (en) 1998-12-30 2006-11-23 Ethicon, Inc. Thread belay device
US6228096B1 (en) 1999-03-31 2001-05-08 Sam R. Marchand Instrument and method for manipulating an operating member coupled to suture material while maintaining tension on the suture material
US6319275B1 (en) * 1999-04-07 2001-11-20 Medtronic Ave, Inc. Endolumenal prosthesis delivery assembly and method of use
US10327743B2 (en) 1999-04-09 2019-06-25 Evalve, Inc. Device and methods for endoscopic annuloplasty
WO2006116558A2 (en) 1999-04-09 2006-11-02 Evalve, Inc. Device and methods for endoscopic annuloplasty
US7666204B2 (en) 1999-04-09 2010-02-23 Evalve, Inc. Multi-catheter steerable guiding system and methods of use
DE60045429D1 (en) 1999-04-09 2011-02-03 Evalve Inc Device for heart valve surgery
ATE470414T1 (en) 1999-06-25 2010-06-15 Vahid Saadat TISSUE TREATMENT DEVICE
US6626899B2 (en) 1999-06-25 2003-09-30 Nidus Medical, Llc Apparatus and methods for treating tissue
US20050192629A1 (en) 1999-06-25 2005-09-01 Usgi Medical Inc. Methods and apparatus for creating and regulating a gastric stoma
EP1207789A4 (en) 1999-08-30 2006-05-31 Applied Med Resources Improved surgical clip
US6378289B1 (en) 1999-11-19 2002-04-30 Pioneer Surgical Technology Methods and apparatus for clamping surgical wires or cables
GB2359024A (en) 2000-02-09 2001-08-15 Anson Medical Ltd Fixator for arteries
US6849077B2 (en) 2000-02-11 2005-02-01 Evysio Medical Devices Ulc Stent delivery system and method of use
US6818001B2 (en) 2000-04-05 2004-11-16 Pathway Medical Technologies, Inc. Intralumenal material removal systems and methods
WO2002015795A2 (en) 2000-08-25 2002-02-28 Sutura, Inc. Suture cutter
US6716243B1 (en) 2000-09-13 2004-04-06 Quickie, Inc. Concentric passive knotless suture terminator
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US6997931B2 (en) 2001-02-02 2006-02-14 Lsi Solutions, Inc. System for endoscopic suturing
US7235086B2 (en) 2001-02-02 2007-06-26 Lsi Solutions, Inc. Crimping instrument with motion limiting feature
US6656221B2 (en) 2001-02-05 2003-12-02 Viacor, Inc. Method and apparatus for improving mitral valve function
US6524328B2 (en) 2001-04-12 2003-02-25 Scion International, Inc. Suture lock, lock applicator and method therefor
US7037334B1 (en) 2001-04-24 2006-05-02 Mitralign, Inc. Method and apparatus for catheter-based annuloplasty using local plications
US6619291B2 (en) 2001-04-24 2003-09-16 Edwin J. Hlavka Method and apparatus for catheter-based annuloplasty
US20060069429A1 (en) 2001-04-24 2006-03-30 Spence Paul A Tissue fastening systems and methods utilizing magnetic guidance
US7033379B2 (en) 2001-06-08 2006-04-25 Incisive Surgical, Inc. Suture lock having non-through bore capture zone
JP2005519645A (en) 2001-06-20 2005-07-07 イーバ コーポレイション Fastener remover and usage
ATE387160T1 (en) 2001-08-31 2008-03-15 Mitral Interventions DEVICE FOR HEART VALVE REPAIR
US6776784B2 (en) 2001-09-06 2004-08-17 Core Medical, Inc. Clip apparatus for closing septal defects and methods of use
US20030060813A1 (en) 2001-09-22 2003-03-27 Loeb Marvin P. Devices and methods for safely shrinking tissues surrounding a duct, hollow organ or body cavity
US7144363B2 (en) 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
US7052487B2 (en) 2001-10-26 2006-05-30 Cohn William E Method and apparatus for reducing mitral regurgitation
US20050177180A1 (en) 2001-11-28 2005-08-11 Aptus Endosystems, Inc. Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ
US6976995B2 (en) 2002-01-30 2005-12-20 Cardiac Dimensions, Inc. Fixed length anchor and pull mitral valve device and method
US6908478B2 (en) 2001-12-05 2005-06-21 Cardiac Dimensions, Inc. Anchor and pull mitral valve device and method
US7238203B2 (en) 2001-12-12 2007-07-03 Vita Special Purpose Corporation Bioactive spinal implants and method of manufacture thereof
US6652562B2 (en) 2001-12-28 2003-11-25 Ethicon, Inc. Suture anchoring and tensioning device
US20050209690A1 (en) 2002-01-30 2005-09-22 Mathis Mark L Body lumen shaping device with cardiac leads
US7048754B2 (en) 2002-03-01 2006-05-23 Evalve, Inc. Suture fasteners and methods of use
US6699263B2 (en) 2002-04-05 2004-03-02 Cook Incorporated Sliding suture anchor
US7056330B2 (en) 2002-05-31 2006-06-06 Ethicon Endo-Surgery, Inc. Method for applying tissue fastener
US7101395B2 (en) 2002-06-12 2006-09-05 Mitral Interventions, Inc. Method and apparatus for tissue connection
US7753922B2 (en) 2003-09-04 2010-07-13 Guided Delivery Systems, Inc. Devices and methods for cardiac annulus stabilization and treatment
US7753924B2 (en) * 2003-09-04 2010-07-13 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US7758637B2 (en) 2003-02-06 2010-07-20 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US7588582B2 (en) 2002-06-13 2009-09-15 Guided Delivery Systems Inc. Methods for remodeling cardiac tissue
US20040243227A1 (en) 2002-06-13 2004-12-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060122633A1 (en) 2002-06-13 2006-06-08 John To Methods and devices for termination
EP1530441B1 (en) 2002-06-13 2017-08-02 Ancora Heart, Inc. Devices and methods for heart valve repair
US7883538B2 (en) * 2002-06-13 2011-02-08 Guided Delivery Systems Inc. Methods and devices for termination
US7666193B2 (en) 2002-06-13 2010-02-23 Guided Delivery Sytems, Inc. Delivery devices and methods for heart valve repair
US7753858B2 (en) 2002-06-13 2010-07-13 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US8287555B2 (en) 2003-02-06 2012-10-16 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US7087064B1 (en) 2002-10-15 2006-08-08 Advanced Cardiovascular Systems, Inc. Apparatuses and methods for heart valve repair
AU2003282982B2 (en) 2002-10-21 2009-07-16 Mitralign Incorporated Method and apparatus for performing catheter-based annuloplasty using local plications
US8979923B2 (en) * 2002-10-21 2015-03-17 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US7247134B2 (en) * 2002-11-12 2007-07-24 Myocor, Inc. Devices and methods for heart valve treatment
US7331972B1 (en) 2002-11-15 2008-02-19 Abbott Cardiovascular Systems Inc. Heart valve chord cutter
US7316708B2 (en) 2002-12-05 2008-01-08 Cardiac Dimensions, Inc. Medical device delivery system
DE10259411A1 (en) 2002-12-19 2004-07-08 Forschungszentrum Karlsruhe Gmbh Medical clip and device for applying such a device
US6866673B2 (en) 2002-12-20 2005-03-15 Ran Oren Suture manipulating and/or cutting implement
US20040138683A1 (en) * 2003-01-09 2004-07-15 Walter Shelton Suture arrow device and method of using
US7257450B2 (en) 2003-02-13 2007-08-14 Coaptus Medical Corporation Systems and methods for securing cardiovascular tissue
US7381210B2 (en) 2003-03-14 2008-06-03 Edwards Lifesciences Corporation Mitral valve repair system and method for use
JP4691017B2 (en) 2003-03-18 2011-06-01 セント ジュード メディカル インコーポレイテッド Body tissue remodeling method and apparatus
US20040267306A1 (en) 2003-04-11 2004-12-30 Velocimed, L.L.C. Closure devices, related delivery methods, and related methods of use
GB2400609A (en) 2003-04-16 2004-10-20 Reckitt Benckiser Multiple-emulsion cleaner
US20040236372A1 (en) 2003-05-20 2004-11-25 Anspach William E. Suture clamp
US7316706B2 (en) * 2003-06-20 2008-01-08 Medtronic Vascular, Inc. Tensioning device, system, and method for treating mitral valve regurgitation
WO2005034738A2 (en) * 2003-10-10 2005-04-21 Proximare, Inc. Patent foramen ovale (pfo) closure devices, delivery apparatus and related methods and systems
EP1689329A2 (en) * 2003-11-12 2006-08-16 Medtronic Vascular, Inc. Cardiac valve annulus reduction system
US20050273138A1 (en) 2003-12-19 2005-12-08 Guided Delivery Systems, Inc. Devices and methods for anchoring tissue
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US7431726B2 (en) 2003-12-23 2008-10-07 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US7635510B2 (en) 2004-07-07 2009-12-22 Boston Scientific Scimed, Inc. High performance balloon catheter/component
WO2006034243A2 (en) 2004-09-17 2006-03-30 0783963 Bc Ltd. Hydrocarbon processing devices and systems for engines and combustion equipment
US7635329B2 (en) 2004-09-27 2009-12-22 Evalve, Inc. Methods and devices for tissue grasping and assessment
US20060135970A1 (en) 2004-11-15 2006-06-22 Laurent Schaller Catheter-based tissue remodeling devices and methods
US8287583B2 (en) 2005-01-10 2012-10-16 Taheri Laduca Llc Apparatus and method for deploying an implantable device within the body
US8109945B2 (en) 2005-02-04 2012-02-07 St. Jude Medical Puerto Rico Llc Percutaneous suture path tracking device with cutting blade
US20060229708A1 (en) 2005-02-07 2006-10-12 Powell Ferolyn T Methods, systems and devices for cardiac valve repair
US8608797B2 (en) 2005-03-17 2013-12-17 Valtech Cardio Ltd. Mitral valve treatment techniques
US8864823B2 (en) 2005-03-25 2014-10-21 StJude Medical, Cardiology Division, Inc. Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen
US8038687B2 (en) 2005-05-17 2011-10-18 St. Jude Medical Puerto Rico Llc Suture loop closure device
US8628541B2 (en) 2005-05-26 2014-01-14 Usgi Medical, Inc. Methods and apparatus for securing and deploying tissue anchors
US20060270976A1 (en) 2005-05-31 2006-11-30 Prorhythm, Inc. Steerable catheter
CA2610796C (en) 2005-06-02 2014-01-07 Cordis Corporation Patent foramen ovale closure device
US20070005394A1 (en) 2005-06-07 2007-01-04 Up Todate Inc. Method and apparatus for managing medical order sets
US8252005B2 (en) 2005-06-30 2012-08-28 Edwards Lifesciences Corporation System, apparatus, and method for fastening tissue
US8951285B2 (en) 2005-07-05 2015-02-10 Mitralign, Inc. Tissue anchor, anchoring system and methods of using the same
US20070055206A1 (en) 2005-08-10 2007-03-08 Guided Delivery Systems, Inc. Methods and devices for deployment of tissue anchors
US9492277B2 (en) 2005-08-30 2016-11-15 Mayo Foundation For Medical Education And Research Soft body tissue remodeling methods and apparatus
US20070093805A1 (en) 2005-10-17 2007-04-26 Coaptus Medical Corporation Systems and methods for securing cardiovascular tissue, including via asymmetric electrodes
US8764820B2 (en) 2005-11-16 2014-07-01 Edwards Lifesciences Corporation Transapical heart valve delivery system and method
US7632308B2 (en) 2005-11-23 2009-12-15 Didier Loulmet Methods, devices, and kits for treating mitral valve prolapse
EP1968492A2 (en) 2005-12-15 2008-09-17 Georgia Technology Research Corporation Systems and methods to control the dimension of a heart valve
US20080058765A1 (en) 2006-08-31 2008-03-06 Pierri Jais Catheter for linear and circular mapping
US20080065156A1 (en) 2006-09-08 2008-03-13 Hauser David L Expandable clip for tissue repair
JP4787363B2 (en) 2006-10-04 2011-10-05 パスウェイ メディカル テクノロジーズ インコーポレイテッド Medical catheter
US8388680B2 (en) 2006-10-18 2013-03-05 Guided Delivery Systems, Inc. Methods and devices for catheter advancement and delivery of substances therethrough
US8197464B2 (en) 2007-10-19 2012-06-12 Cordis Corporation Deflecting guide catheter for use in a minimally invasive medical procedure for the treatment of mitral valve regurgitation
CA2713934C (en) 2008-02-06 2015-10-20 Guided Delivery Systems, Inc. Multi-window guide tunnel
US9314335B2 (en) 2008-09-19 2016-04-19 Edwards Lifesciences Corporation Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation
KR20110084912A (en) 2008-10-10 2011-07-26 가이디드 딜리버리 시스템즈 인코퍼레이티드 Tether tensioning devices and related methods
BRPI0920406A2 (en) 2008-10-10 2019-09-24 Guided Delivery Systems Inc termination devices and related methods.
WO2010085456A1 (en) 2009-01-20 2010-07-29 Guided Delivery Systems Inc. Anchor deployment devices and related methods
EP2389218A4 (en) 2009-01-20 2012-06-13 Guided Delivery Systems Inc Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040186486A1 (en) 1999-09-20 2004-09-23 Ev3 Sunnyvale, Inc. Method of closing an opening in a wall of the heart
US20020133092A1 (en) 2001-03-16 2002-09-19 Microvena Corporation Wire convertible from over-the-wire length to rapid exchange length

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2081627A4

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2412397A1 (en) * 2006-10-18 2012-02-01 Guided Delivery Systems, Inc. Catheter for implant deployment
US8388680B2 (en) 2006-10-18 2013-03-05 Guided Delivery Systems, Inc. Methods and devices for catheter advancement and delivery of substances therethrough
US9125632B2 (en) 2007-10-19 2015-09-08 Guided Delivery Systems, Inc. Systems and methods for cardiac remodeling
EP3915490A1 (en) * 2007-10-19 2021-12-01 Ancora Heart, Inc. Systems for cardiac remodeling
EP3854315A1 (en) * 2007-10-19 2021-07-28 Ancora Heart, Inc. Systems for cardiac remodeling
WO2009052427A1 (en) * 2007-10-19 2009-04-23 Guided Delivery Systems Inc. Systems and methods for cardiac remodeling
US10363392B2 (en) 2008-05-07 2019-07-30 Ancora Heart, Inc. Deflectable guide
US10625047B2 (en) 2009-01-20 2020-04-21 Ancora Heart, Inc. Anchor deployment devices and related methods
US9173646B2 (en) 2009-01-20 2015-11-03 Guided Delivery Systems Inc. Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods
US11202883B2 (en) 2009-01-20 2021-12-21 Ancora Heart, Inc. Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods
US10625046B2 (en) 2009-01-20 2020-04-21 Ancora Heart, Inc. Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods
US10016195B2 (en) 2012-09-20 2018-07-10 Medos International Sarl Suture leader
AU2018203869B2 (en) * 2012-09-20 2019-09-12 Depuy Mitek, Llc Suture leader
CN103654890A (en) * 2012-09-20 2014-03-26 德普伊米特克有限责任公司 Suture leader
EP2710964A3 (en) * 2012-09-20 2014-06-11 DePuy Mitek, LLC Suture leader
US9247936B2 (en) 2012-09-20 2016-02-02 Medos International Sarl Suture leader
CN105120801A (en) * 2013-03-20 2015-12-02 马尔科·沃拉 Device for carrying out a transapical mitral valve annuloplasty
US9968453B2 (en) 2013-03-20 2018-05-15 Marco Vola Device for carrying out a transapical mitral valve annuloplasty
FR2998167A1 (en) * 2013-03-20 2014-05-23 Marco Vola DEVICE FOR PERFORMING AN ANNULOPLASTY BY THE TRANSAPICAL PATH OF THE MITRAL VALVE
WO2014147336A1 (en) * 2013-03-20 2014-09-25 Vola Marco Device for carrying out a transapical mitral valve annuloplasty
US10980529B2 (en) 2015-03-05 2021-04-20 Ancora Heart, Inc. Devices and methods of visualizing and determining depth of penetration in cardiac tissue
US10058321B2 (en) 2015-03-05 2018-08-28 Ancora Heart, Inc. Devices and methods of visualizing and determining depth of penetration in cardiac tissue
US10722359B2 (en) 2016-08-26 2020-07-28 Edwards Lifesciences Corporation Heart valve docking devices and systems
US11690708B2 (en) 2016-08-26 2023-07-04 Edwards Lifesciences Corporation Heart valve docking system
US11801133B2 (en) 2016-08-26 2023-10-31 Edwards Lifesciences Corporation Heart valve docking devices and systems
WO2019164516A1 (en) * 2018-02-22 2019-08-29 Edwards Lifesciences Corporation Heart valve docking devices and systems
CN111970993A (en) * 2018-02-22 2020-11-20 爱德华兹生命科学公司 Heart valve docking device and system
US11672524B2 (en) 2019-07-15 2023-06-13 Ancora Heart, Inc. Devices and methods for tether cutting

Also Published As

Publication number Publication date
AU2018213993B2 (en) 2020-04-09
CA2666862C (en) 2015-04-14
JP2010506658A (en) 2010-03-04
EP2412397A1 (en) 2012-02-01
AU2018213993A1 (en) 2018-08-23
EP2081627A4 (en) 2010-06-30
AU2016266039A1 (en) 2017-01-12
EP3095394B1 (en) 2018-04-18
US8388680B2 (en) 2013-03-05
AU2007313197A1 (en) 2008-04-24
EP2412397B1 (en) 2016-07-13
EP2081627A2 (en) 2009-07-29
IL198206A0 (en) 2009-12-24
EP3420921A1 (en) 2019-01-02
AU2014203477B2 (en) 2016-09-01
AU2016266039B2 (en) 2018-05-10
EP3095394A1 (en) 2016-11-23
WO2008048626A3 (en) 2008-06-26
AU2007313197B2 (en) 2014-04-03
AU2014203477A1 (en) 2014-07-17
US20080172035A1 (en) 2008-07-17
CA2666862A1 (en) 2008-04-24
EP3420921B1 (en) 2023-06-28

Similar Documents

Publication Publication Date Title
AU2016266039B2 (en) Methods and devices for catheter advancement and delivery of substances therethrough
US20200345980A1 (en) Anchor deployment devices and related methods
US20200229820A1 (en) Multi-window guide tunnel
EP2217153B1 (en) Systems for cardiac remodeling
JP2007510525A (en) Heart annulus reduction system
CN105263423A (en) Percutaneous valve repair by reshaping and resizing right ventricle
WO2009038724A1 (en) Devices, systems, and methods for reshaping a heart valve annulus, including the use of a bridge implant having an adjustable bridge stop

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07852809

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2009533354

Country of ref document: JP

Kind code of ref document: A

Ref document number: 2666862

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 198206

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2007313197

Country of ref document: AU

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007852809

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2007313197

Country of ref document: AU

Date of ref document: 20071016

Kind code of ref document: A